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“Živi kao da ćeš sutra umreti. Uči kao da ćeš večno živeti.” 
Monitoring of in vitro bioavailability and uptake of glycosylated food allergens 
using cell-based models 
 
SUMMARY 
The increasing problem of food allergies in the population worldwide requires 
the extensive engagement of researchers in the elucidation of the mechanisms 
underlying processes of food digestion, allergen transport, and uptake by the immune 
cells and its effector immune responses. The development of the in vitro assays and 
cell-based models has allowed bridging the problem of food allergy research and the 
respect of the ethical norms in used research procedures.  
The red meat allergy is a novel type of food allergy characterized by the 
production of an IgE antibody against the carbohydrate galactose-α-1,3-galactose (α-
Gal). Glycoproteins from non-primate mammals are rich with an α-Gal as post-
translational modification. Also, red meat allergy is characterized by the delayed onset 
of symptoms which may be related to the mechanism and the fate of α-Gal carrying 
proteins in the human gastrointestinal tract. Furthermore, the uptake, processing, and 
mechanisms of presentation of α-Gal by the immune cells are still unknown. Therefore 
this doctoral dissertation aimed to investigate how protein glycosylation by α-Gal 
affects their susceptibility to gastric digestion, does α-Gal conjugated to proteins affects 
their transport through the Caco-2 cell monolayer, which mimics the gastrointestinal 
layer, and to examine the influence of α-Gal epitopes on the protein surface on their 
uptake and processing by immature monocyte-derived dendritic cells (iMDDCs). The 
study revealed that the presence of the α-Gal glycosylation on protein surface had an 
impact on their susceptibility to gastric digestion and the digestion pattern of the 
obtained protein fragments upon pepsinolysis. Prolonged survival, up to 2h of digestion, 
was characteristic of the large proteins fragments bearing the α-Gal epitope. 
Importantly, transport through the Caco-2 monolayer of proteins conjugated to α-Gal 
was hampered in comparison to unconjugated proteins. Furthermore, differential 
centrifugation of Caco-2 cell lysates upon transport experiments revealed that α-Gal 
could be detected on the intact protein in the endosomal fraction of the cells. Also, the 
level of galectin-3, which is abundantly expressed by intestinal epithelial cells and is 
possibly associated with pro-inflammatory properties, was not altered by the presence of 
α-Gal glycosylated BSA (bovine serum albumin) (BSA-α-Gal) in comparison to BSA. 
To monitor the influence of α-Gal epitopes on the protein surface on their uptake and 
processing iMDDCs were prepared from healthy blood donors and red meat allergic 
patients. Overtime increased internalization of α-Gal carrying proteins in iMDDCs from 
healthy individuals and red meat allergic patients was noted. The flow cytometric 
analysis also revealed that the uptake of α-Gal carrying proteins was significantly higher 
than the uptake of non-α-Gal carrying proteins. For analysis of the spatial distribution of 
α-Gal carrying proteins inside iMDDCs confocal microscopy was employed and 
interestingly α-Gal carrying proteins were scattered around the cytoplasm while 
detection of proteins not carrying α-Gal was negligible. Upon uptake experiments, the 
iMMDCs lysates were prepared and resolved on sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis which showed that α-Gal carrying proteins were processed to a 
lesser extent compared to non-α-Gal carrying proteins.  
As a general conclusion, it can be underlined that glycosylation of food proteins 
has effects on their digestibility and transport through the intestinal monolayer and on 
their successive uptake and processing by cells of the immune system. This thesis has 
established new in vitro protocols as well as protocols for setting up cell-based models 
that, in addition to examining the effects of glycosylated food allergens, may be used in 
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Praćenje in vitro biousvojivosti i preuzimanja glikozilovanih alergena hrane 
upotrebom ćelijskih modela  
 
REZIME 
Alergije na hranu su rastući problem u ljudskoj populaciji širom sveta i 
rešavanje ovog problema zahteva opsežno angažovanje istraživača u rasvetljavanju 
mehanizama uključenih u procese varenja hrane, transporta alergena i njihovog unosa 
od strane imunih ćelija odgovornih za efektorske mehanizme imunoloških odgovora. 
Ovo je nezamislivo bez razvoja in vitro testova i ćelijskih modela koji premošćuju 
problem istraživanja alergija na hranu uz poštovanja etičkih normi u korišćenim 
istraživačkim metodama. 
Novu vrstu alergije na hranu, alergiju na crveno meso, karakteriše sinteza 
imunoglobulina E kao odgovor na prisustvo šećera galaktoza-α-1,3-galaktoza (α-Gal), 
koji je prisutan na površini glikoproteina primata. Takođe, alergiju na crveno meso 
karakteriše odložena pojava simptoma što može biti rezultat promena u mehanizmu 
obrade proteina koji nose α-Gal u gastrointestinalnom traktu čoveka. Dalje, unos, 
obrada i mehanizmi prezentacije α-Gal šećera od strane imunih ćelija još uvek nisu 
poznati. Stoga ciljevi ove doktorske disertacije su ispitivanje kako α-Gal glikozilacija 
proteina utiče na njihovu digestiju od strane pepsina, da li α-Gal glikozilacija proteina 
utiče na njihov transport kroz monosloj Caco-2 ćelija, koji oponaša gastrointestinalni 
epitel, kao i ispitivanje uticaja α-Gal glikozilacije na površini proteina na njihov unos i 
obradu od strane nezrelih dendritičnih ćelijama kultivisanih iz monocita (iMDDC). Iz 
dobijenih rezultata moze se zaključiti da prisustvo α-Gal glikozilacije na površini 
proteina utiče na njihovu podložnost na digestiju a najviše na obrazac dobijenih 
fragmenata proteina nakon pepsinolize. Veliki fragmenti proteina koji nose α-Gal 
prisutni su čak i do 2 sata digestije. Takođe, važno je istaći da je transport α-Gal 
glikozilovanih proteina kroz Caco-2 monosloj otežan u poređenju sa neglikozilovanim 
proteinima. Dalje, diferencijalnim centrifugiranjem lizata  aco-2 ćelija nakon 
transcitoze pokazalo je da je α-Gal prisutan na intaktnim proteinima u endozomalnim 
frakcijama ćelija. Takođe, nivo galektina-3, koji je obilno eksprimiran na intestinalnim 
epitelnim ćelijama i za koji se veruje da je u sprezi sa mehanizmima alergijskih reakcija, 
ne menja se u prisustu BSA (goveđi serum albumin) glikozilovanog α-Gal-om (BSA-α-
Gal) u poređenju sa neglikozilovanim BSA. Da bi se ispratio uticaj α-Gal glikozilacije 
proteina na njihov unos i obradu od strane ćelija imunog sistema, korišćeni su iMDDC 
uzeti  od zdravih davalaca krvi i pacijenata sa alergijom na crveno meso.  rimećena je 
povećana internalizacija α-Gal glikozilovanih proteina od strane iMDDC i zdravih 
osoba i pacijenata sa alergijom na crveno meso. Korišćenjem metoda protočne 
citometrije došlo se do rezultata da je unos proteina, od strane iMDDCs, koji nose α-Gal 
bio znatno veći od unosa proteina koji nemaju α-Gal. Za analizu prostorne distribucije 
proteina koji nose α-Gal unutar iMDD s korišćena je konfokalna mikroskopija i 
zanimljivo je da su proteini koji nose α-Gal rasuti po citoplazmi, dok je detekcija 
proteina koji ne nose α-Gal zanemarljiva. Nakon preuzimanja proteina od strane 
iMMDCs, pripremljeni su lizati ovih ćelija čiji su proteini razdvojeni u gelu 
elektroforetskom tehnikom, ovo je pokazalo da su proteini koji nose α-Gal procesovani 
u manjoj meri u poređenju sa proteinima koji ne nose α-Gal. 
Kao opšti zaključak, može se navesti da glikozilacija proteina hrane utiče na 
njihovu digestibilnost i transport kroz intestinalni monosloj kao i na njihovo dalje 
preuzimanje i procesovanje od strane ćelija imunog sistema. Takođe, kao jedno od 
postignuća ove doktorske disertacije treba istaći i uspostavljanje novih in vitro 
protokola kao i protokola za uspostavljanje ćelijskih modela, koji se, pored ispitivanja 
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Nowadays with the emerging problem of increase of food allergies in the 
population worldwide, research on the mechanism underlying processes of food 
digestion, allergen transport, and uptake by the immune cells and its effector immune 
responses is necessary. The research community, as well as our modern society, agrees 
that the establishment and improvement of in vitro models are required. Therefore 
efforts of many researchers are directed toward the development and improvement of in 
vitro models such as cell-based models to monitor and examine the physiological and 
pathological processes which occur in the human gut and are responsible for the 
development of food allergies.   
To better understand and explain processes related to food processing in the 
human gut it is necessary to define the frequently used term bioavailability. In general, 
bioavailability refers to gastrointestinal digestion, absorption, tissue distribution, 
metabolism, and bioactivity. Bioavailability is usually defined as “the fraction of 
ingested nutrient or compound that reaches the systemic circulation and is utilized”. 
Furthermore, the term bioavailability also means that the compound of interest is 
efficiently digested and absorbed, and as such exhibits effects on human health. 
However, already mentioned ethical restrictions as well as practical difficulties in the 
assessment of effects of food compounds on human health narrow the term 
bioavailability and define it as “the fraction of a given compound or its metabolite that 
reaches the systemic circulation without considering bioactivity” (Wood 2005, Holst 








2. Theoretical part  
The theoretical part of this doctoral dissertation provides background and theoretical 
knowledge essential for understanding the rationale, relevance, and significance of the 
conducted research. 
2.1. Immune system 
The immune system represents the defense system enrolled in the protection from the 
invading pathogens. The origin of the term immunity is Latin, derived from the word 
immunitas which means “exempt from public service” and referred to as a legal 
exemption from military service in ancient Rome. A science that deals with the study of 
the immune system is immunology and Louis Pasteur is considered to be the father of 
modern immunology due to its efforts to firmly establish the germ theory of disease 
during the 1860s. Interestingly, the practice of variolation was spread throughout 
England in the 1740s, but vaccination is not introduced before 1798 by Edward Jenner 
who realized that individuals who had cow’s pox do not get smallpox. Although 
Jenner’s observation was correct, it was not supported by an understanding of how 
immunity develops (Smith 2012). Besides infectious, non-infectious agents can also 
provoke responses of the immune system. Therefore one of the definitions of the 
immune response is: “reactions to the components of microbes as well as to 
macromolecules such as proteins and polysaccharides and low molecular weight 
chemicals that are recognized as foreign, regardless of the physiologic or pathologic 
consequence of such a reaction” (Abbas, Lichtman et al. 2007).  
The host immunity can be divided into innate and adaptive immunity (Figure 1). The 
innate immunity or native is characterized by early reactions, during several hours after 
exposure of an organism to pathogens, and provides an early line of defense against 
microbes. The principal components of innate immunity are epithelial cells and their 
antimicrobial substances, phagocytic and natural killer cells, blood proteins (members 
of the complement system), and cytokines. The adaptive immunity is stimulated by the 
successive exposure to the “invaders” e.g. microbes and increases in extent and 
defensive potential with each exposure. There are two types of adaptive immune 
responses, called humoral immunity in which macromolecules like antibodies produced 




in B lymphocytes are involved and cell-mediated immunity mediated by T lymphocytes 
(Abbas, Lichtman et al. 2007). The immune system fulfills its protective role through 
several important functions such as detection of the threat, which is referred to as 
immunological recognition; elimination of the threat by various immune’s effector 
functions, prevention and decrease of damage to the host by immune regulation and 
development of immunological memory to respond quickly to future threats.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
Figure 1. The host immunity – innate and adaptive immunity.
1
 NK cells – natural 
killer cells 
Failure and errors in the immune regulation lead to disease states such as allergy and 
autoimmune disease. The mechanism of allergic reactions can be divided into two 
phases (a) sensitization and memory and (b) effector phase. During the sensitization 
phase (Figure 2) allergens that reach and/or pass through the epithelial layer of gut, skin, 
or airways are being encountered by the resident dendritic cells (DCs), captured, 
processed, and presented within the major histocompatibility complex (MHC) class II 
molecules on the cell surface. In the lymph node antigen-presenting, DCs establish 
communication with naïve CD4
+ 
T cells which further differentiate into allergen-
                                                          
1
 Reprinted from Abbas, A. K., A. H. Lichtman and S. Pillai (2007). Cellular and molecular immunology, 






Th2 cells. Furthermore, naïve B cells under the stimuli of Th2 cell, which 
produce high levels of interleukins (ILs) IL-4 and IL-13, and by recognition of 
endogenous antigens via IgM B cell receptor activate IgE isotype class-switching and 
differentiate into IgE memory B cells which can mature and differentiate into plasma 
cells. Plasma cells produce allergen-specific IgE antibodies which bind to the high-
affinity IgE receptor (FcεRI) on the surface of basophils and mast cell. During the 
sensitization phase, there are no symptoms of allergy. Interestingly several studies have 
demonstrated that epithelial cells from resident epithelia are involved in this phase of 
sensitization, e.g. epithelial cells can produce cytokines such as IL-25, IL-33, IL-31, or 
thymic stromal lymphopoietin (TSLP or IL-7) upon stimulation contributing to the 
generation of allergen-specific CD4+ Th2 cells and allergic sensitization. Moreover, 
epithelial cells are key players in establishing immune tolerance to allergens 
(Palomares, Akdis et al. 2017). 




Figure 2. Mechanism of allergic sensitization.
2
 TSLP - thymic stromal lymphopoietin, 
DC - dendritic cell, NKT cell - natural killer T cell, Ig - immunoglobulin, MHC - major 
histocompatibility complex, TCR – T cell receptor, Th – T helper. 
The effector phase of the allergic reactions occurs when re-encountering the allergen 
leads to crosslinking of the IgE bound to FcεRI on the sensitized basophils and mast 
cells (Figure 3). This leads to the release of mediators such as histamine, heparin, 
proteases, prostaglandins, leukotrienes, and cytokines from activated basophils and mast 
cells referred to as the early stage of the IgE mediated hypersensitivity reaction. Besides 
the early stage of hypersensitivity, the allergic reaction can be also characterized by a 
late phase which starts several hours after exposure to the allergen. The release of 
mediators by basophils and mast cells triggers long-term inflammatory processes that 
involve attracting various immune cells to allergen sites, including Th2 lymphocytes, 
eosinophils, basophils, and monocytes. (Palomares, Akdis et al. 2017). During the 
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effector phase, individuals can experience various symptoms ranging from mild to 
severe anaphylactic reactions.  
Figure 3. Effector phase of an allergic reaction.
3
IL – interleukin, Ig – immunoglobulin, 
IFN-γ – interferon γ, ILC2 – innate lymphoid cell type 2, Th – T helper, NKT cell - 
natural killer T cell.   
2.1.1. The immune system underlying the gastrointestinal barrier  
The immune system underlying the gastrointestinal tract (GIT) is a part of the 
common mucosal immune system (Figure 4). The widely used term “common mucosal 
immune system” should be replaced by the term “integrated mucosal immune system” 
since there is more and more evidence that immunization in one part of the mucosal 
immune system does not protect all other mucosal organs (Pabst and Rothkötter 2006). 
Although originally belonging to the cells of the intestinal epithelia, the cells specialized 
in sampling and presentation of antigens on the luminal side of GIT are microfold cells 
(M cells). M cells are located in intestinal lymphoid structures such as  ayer’s patches 
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and isolated lymphoid follicles. The most abundant immune cell type underlying 
intestine are mononuclear phagocytes or macrophages and DCs. The main role of these 
cells is a sampling of the content in GIT and to orchestrate both innate and adaptive 
immune responses.  
The immune cells are characterized and differ by the expression of some surface 
markers, macrophages with surface expression of CD11c and CX3CR1 are recognized 
as the intestinal macrophages involved in the antigen sampling which do not migrate to 
the mesenteric lymph nodes in physiological conditions (Schulz, Jaensson et al. 2009). 
Besides macrophages and DCs, lymphocytes are present in the intestinal mucosa. Naïve 
lymphocytes are primed in  ayer’s patches and mesenteric lymph nodes and through the 
expression of the gut-homing chemokine receptor 9 and integrin α4β7 can migrate 
within the gut (Mora, Bono et al. 2003). Plasma cells that produce IgA antibodies and 
CD4
+ 
T cells are mainly distributed in the lamina propria while CD8
+ 
T cells are in the 
epithelium (Mowat 2003). Different subsets of CD4
+ 
T cells are present such as T helper 
(Th) cells like Th17, which produce IL-17, Th1, and T regulatory (Treg) cells. 
Furthermore, Treg cells can be divided into two subsets of cells forkhead box protein P3 
(Foxp3) and Type 1 regulatory T (Tr1) cells which are both involved in the tolerogenic 
immune response. Innate lymphoid cells (ILCs) are recently discovered cells in the gut 
which also belong to the immune system. The main characteristic of ILCs is that they do 
not possess receptors and upon stimulation do not undergo clonal selection. Within this 
cell population three cell subsets, ILC1, ILC2, and ILC3, can be recognized. ILC1 
resemble the most the natural killer (NK) cells but unlike them lack cytolytic activity 
and have a different developmental pathway. It is believed that ILC2 are typically 
associated with the Th2-response, while ILC3 produce high amounts of IL-17A, IL-22 
and granulocyte-macrophage colony-stimulating factor (GM-CSF) (Walker, Barlow et 
al. 2013, Parigi, Eldh et al. 2015, Geremia and Arancibia-Cárcamo 2017). The all stated 
above demonstrates the complexity of the gut immune system and the complex interplay 
ongoing among the different subsets of the immune cells which are present in the layers 
under the intestinal barrier. 





Figure 4. The immune cells underlying the gastrointestinal barrier.
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 IEL -  
Intraepithelial lymphocyte, M cell - Microfold cell, TREG – T regulatory cell, TH – T 
helper, ILC - Innate lymphoid cells, Ig – Immunoglobulin, Ly6
hi
 - lymphocyte antigen 6 
“high” monocyte. 
2.1.1.1. Dendritic cells  
Dendritic cells were discovered in the 1970s by two scientists Ralph Steinman and 
Zanvil Cohn (Steinman and Cohn 1973), but their role in the immune system was 
discovered 40 years later. Dendritic cells efficiently stimulate B and T lymphocytes. 
While B cells can directly recognize antigen through their receptors, T cells need 
antigen to be processed and presented to them by the antigen-presenting cells to get 
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activated. Antigen-presenting cells possess on their surface the MHC molecules within 
which they present fragments of the processed antigens. On the other side, T cells 
possess T cell antigen receptors (TCRs) which recognize antigen fragments presented 
by the MHCs. There are two types of MHC molecules, MHC class I which stimulate 
cytotoxic T cells, and MHC class II which stimulates T helper cells. APCs process and 
present intracellular antigens within MHC class I molecules to cytotoxic T cells which 
upon activation directly kill a target cell. On the other hand, extracellular antigens 
uptaken and processed by the APCs are presented within MHC class II to the Th cells 
which are involved in the immune-regulation (Abbas, Lichtman et al. 2007).  
Dendritic cells can be classified as plasmacytoid DCs (pDCs) and classical DCs 
(cDCs). The plasmacytoid DCs unlike cDCs express low levels of MHC class II, 
costimulatory molecules, and CD11c integrin as well as pattern-recognition receptors 
(PRRs) such as Toll-like receptors (TLRs). Upon recognition and uptake of foreign 
nucleic acid molecules, pDCs produce high amounts of type I interferon and acquire the 
ability to present foreign antigens (Merad, Sathe et al. 2013). The classical DCs have an 
important role in capturing foreign antigens and their subsequent processing and 
presentation to T lymphocytes, and also in sensing tissue injuries. Also, cDCs are 
involved in the development of tolerance to self-antigens which are cellular proteins, 
peptides, enzyme complexes, ribonucleoprotein complexes, DNA, and post-
translationally modified antigens. In the human body, it is estimated that cDCs 
contribute from 1 to 5 % to the total cell number of a specific organ, and that depending 
on the classification of DCs. The estimation of the number of cDCs in some organs can 
be quite complex, especially in the human intestine.  
The cDCs in the gut are organized within lymphoid tissue such as  eyer’s patches, 
draining lymph nodes as well as in the lamina propria of the small intestine and colon. 
The cDCs have been divided into subsets according to the expression of specific 
markers or according to the cellular origin. The surface markers according to which 
DCs can be classified are:  D8α,  D11b (also known as integrin αM),  D24,  D64 
(also known as FcγRI), CD103 (also known as integrin αE), CD172a (also known as 
SIR α and SH S1), CX3C-chemokine receptor 1 (CX3CR1), F4/80, XC- chemokine 
receptor 1 (XCR1), CLEC9A (also known as DNGR1) and E-cadherin (also known as 




cadherin 1). The cDCs in the lamina propria can be divided into cDC1 which express 
XCR1 and cDC2 which express signal regulatory protein α (SIR α/ D172a). The cDC2 


















. According to the cellular origin cDCs in 
the lamina propria originate from pre-cDC progenitor under the stimuli of cytokine 
Fms-like tyrosine kinase 3 ligands (FLT3L). The main characteristic of the cDCs in the 
lamina propria is their ability to migrate to the draining lymph nodes in a CCR7-
dependent manner and more importantly to interact with recirculating T cells 
(Banchereau and Steinman 1998, Guilliams, Ginhoux et al. 2014, Stagg 2018). 
2.2. Organization of the gastrointestinal tract 
The definition of the GIT also called the alimentary canal, is “an open-ended or 
hollow-like tube, organized into regions and layers with each having peculiar features in 
structure and functions” (Welcome 2018). The components of the GIT are mouth, 
pharynx, esophagus, stomach, small intestine, large intestine, rectum, and anus (Figure 
5). The components of the upper GIT tract are the mouth, pharynx, esophagus, and 
stomach, while the lower GIT includes the small and large intestine, rectum, and anus. 
The important feature of the digestive system is that it connects other systems such as 
the endocrine, lymphatic, muscular, nervous, circulatory, respiratory, urinary, 
reproductive, skeletal, and integumentary. The major tissue types which form the GIT 
and associated organs (liver and pancreas) are epithelial, muscle, nervous, and 
connective tissue which are formed from different cells associated and with a specific 
function (Welcome 2018). 





Figure 5. The organization of the gastrointestinal tract in the adult human.
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The small intestine (average length 5 – 6 m) consists of the duodenum, jejunum, and 
ileum and it is the major site for nutrients and drug absorption which is enabled by the 
great surface area.  The average length of the duodenum is 25 cm, the jejunum is around 
2.5 m and the ileum is 3 m. The major absorptive cells of the small intestine are 
enterocytes which on the luminal surface contain microvilli. The great surface area of 
the small intestine is achieved by the tightly wrinkled interior cell wall which forms the 
so-called intestinal crypts built from enterocytes organized in the finger-like structures 
known as the villi which additionally increase the surface area from 0.33 m
2
 to 120 m
2
 
with the villi and microvilli extensions (Figure 6) (Kararli 1995). 
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Figure 6. Organization of the small intestine.
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2.2.1. The intestinal barrier 
The intestinal barrier is composed of the physical, biochemical, and immune 
elements but the main component is the intestinal epithelial layer which represents the 
physical barrier between the lumen of the GIT and the body. The lumen of the intestine 
which is in direct contact with the outer environment is coated with a mucus layer. 
Besides as a physical barrier, the secreted mucus facilitates the movement of food 
through the intestine. The rigid structure of the mucus-building proteins and its high 
cohesion give mucus the sticky gel-forming appearance. The major components of the 
mucus layer are mucins secreted by the goblet cells (GCs) located in the intestinal 
epithelial layer among enterocytes (Figure 7). Mucins are high molecular weight 
glycoproteins characterized by a high content of sugar moieties that are attached to the 
amino acids side-chains of serine or threonine by O-glycosidic bonds (Johansson and 
Hansson 2013). Changes in the patterns of mucin secretion are probably the primary 
event in  rohn’s disease or secondary event during inflammation of GIT (Niv 2016). 
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Figure 7. Organization and belonging cells of the intestinal epithelial layer.
7
 M cell - 
Microfold cell, CBC stem cell - crypt base columnar stem cells. 
The intestinal epithelial layer of villus and crypts consists of enterocytes as major 
absorptive cells, goblet cells (GCs), enteroendocrine cells, Paneth cells, stem cells, and 
tuft cells (Figure 7) (Okumura and Takeda 2017). The GCs are specialized in mucus 
secretion and are scattered among enterocytes in the epithelium of the small intestine 
and colon. Interestingly, the number of GCs along GIT ranging from relatively few in 
the duodenum up to many cells in the colon. Recent findings suggest that except for 
their role in the barrier maintenance GCs are involved in innate immunity. These cells 
beside mucins can secrete anti-microbial proteins, chemokines, and cytokines, but 
furthermore, they are capable of forming the goblet cell-associated antigen passages and 
induction of the adaptive immune responses (Knoop and Newberry 2018). 
Enteroendocrine cells are localized individually among the enterocytes and other 
exocrine cells of the villus. The main function of these cells is the production of gut 
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hormones which have key roles in the coordination of processes such as food digestion 
and absorption, secretion of insulin, and appetite regulation (Gribble and Reimann 
2019). Paneth cells are located at the ends of intestinal crypts and their role is to secrete 
antibacterial proteins such as defensins to protect adjacent stem cells inside of the wall 
of the crypt (Ganz 2000). The intestinal stem cells are undifferentiated cells capable of 
continuous cell division to replenish the intestinal epithelium. Stem cells and 
approximately once every four days completely replace all the enterocytes and GCs 
(Umar 2010). The tuft cells located in the villus have an important role in promoting 
immunity against parasitic helminths and protozoa. Studies on the mice showed that tuft 
cells are capable of producing IL-25 which further promotes the rapid expansion of 
ILC2. Interestingly, tuft cells possess chemosensory receptors for sweet, bitter, and 
umami taste and they are involved in the perception of compounds with these tastes in 
food (Harris 2016).  
2.2.1.1. Enterocytes 
The enterocytes are the main building blocks of the intestinal epithelial layer of the 
villus and they have the main role in the digestion process so they are well-studied. 
Enterocytes are the main absorptive cells responsible for the uptake of ions, water, 
nutrients, vitamins, and unconjugated bile salts. Besides this role, recently it was 
discovered that they have an important role in the induction of oral tolerance to food 
proteins. The establishment and maintenance of oral tolerance is a very complex and 
demanding process that requires the participation of enterocytes in the numerous 
mechanisms. Those mechanisms include the constant communication between 
enterocytes and the intestinal mucosa-associated lymphoid tissue (MALT) to maintain 
the tolerance to food and microbial antigens (Miron and Cristea 2012). It is 
demonstrated that enterocytes possess the so-called pattern-recognition receptors 
(PRRs), including Toll-like receptors (TLRs), by which they can sense the presence of 
microbes (Hornef and Bogdan 2005).  
The transport of the allergens from the lumen of the intestine to the underlying 
immune system occurs by several routes: by paracellular diffusion, via M cells in 
Peyer’s patches, via goblet cell-associated antigen passage, and by enterocyte 
transcytosis. Uptake of allergens by enterocytes can occur as an active process under 




stimuli of the pre-existing allergen-specific IgA and IgE antibodies because enterocytes 
possess low-affinity IgE receptor designed as CD23 (Tu, Salim et al. 2005). Enterocytes 
constitutively express a low level of MHC class II molecules and in conditions of 
mucosal inflammation such as inflammatory bowel disease the expression of the MHC 
class II molecules increases (Mayer, Eisenhardt et al. 1991). Cathepsin proteases 
involved in the MHC class II-mediated antigen processing are also constitutively 
expressed. Furthermore in the enterocytes two distinct pathways of MHC class II 
antigen processing are noted, one in the presence of inflammation and another in its 
absence (Hershberg, Framson et al. 1997). Enterocytes are very dynamic cells and in 
constant contact with adjacent cells and tissues, actively communicating with T-cells, 
dendritic cells, granulocytes, monocytes, macrophages, and mast cells (Shaykhiev and 
Bals 2007). 
2.3. Food digestion 
  The process of food digestion involves mechanical, chemical, and enzymatic 
food breakdown. Food digestion starts in the mouth where food is chewed and mixed 
with saliva. The saliva contains the digestive enzyme α-amylase which is secreted by 
the parotid glands. Alpha-amylase catalyzes the reaction of starch hydrolysis into 
maltose and other small glucose polymers with three to nine glucose units (Munegumi, 
Inutsuka et al. 2016). But less than 5 % of the starch is hydrolyzed in the mouth because 
the food remains there for less than 5 min (Woolnough, Bird et al. 2010). Next, the 
slippery broken-down food mass named bolus moves to the lower parts of the digestive 
tract. Through the pharynx, the bolus arrives at the esophagus where peristaltic 
contractions and the pressure of the bolus stimulate the lower esophageal sphincter to 
open and food moves into the stomach. The digestion process continues in the stomach 
which strong muscular contractions additionally mix and mash the food. The lumen of 
stomach wall which is in the direct contact with outer environment is coated with 
different types of cells. These cells secrete mucus, hydrochloride acid and enzyme 
pepsin which additionally contributed to the digestion of bolus, which after mechanical, 
chemical and enzymatic digestion becomes semiliquid mass named chyme. Importantly, 
a thick layer of mucus coats the stomach wall in order to protect it from digesting itself. 
The time which food spends in the stomach depends on the food composition, meals 




which have high fat and protein content take longer to break down compared to meals 
with high carbohydrate content. Usually it takes a few hours to completely empty the 
stomach content. From the stomach, chyme enters into the duodenum, and digestion is 
aided by the juices secreted by the liver, pancreas, and gallbladder. An interesting fact is 
that pancreas secrets up to 1.5 liters of pancreatic juice per day which is composed of 
water and contains bicarbonate ions which are very important in the neutralization of 
the acidic chyme and enzymes which are important for a further breakdown of the 
proteins, lipids, and carbohydrates. Furthermore, bile is excreted in the intestine which 
is required for lipid digestion. Bile is synthesized in the liver, stored in the gallbladder, 
and excreted via a duct. In the intestine, bile surrounds the fats and acts as an emulsifier 
e.g. detergent which emulsifies fats. This process is very important for the digestion of 
fats because allows fat to move in the intestinal water environment and its digestion by 
lipase. Because of the peristaltic contraction of a muscle in the intestinal wall, chyme 
moves in this part of GIT into both directions back and forth this enables further chyme 
mixing. In the intestine, a big portion of the meal components are completely broken 
down and chyme is now a mixture of amino acids, emulsified fatty acids, and 
monosaccharides. The absorbing surface area in the intestine is enormous (120 m
2
) and 
covered with a thick layer of mucus which enables that nutrients such as amino acids, 
monosaccharides, water-soluble vitamins, and other components reach to enterocytes, 
the main absorptive cells. These compounds are transported through epithelia by trans-
cellular transport and reach blood circulation. On the other hand, the major products of 
lipid digestion like fatty acids and 2-monoglycerides, as well as, fat-soluble vitamins 
and other lipids enter the enterocyte by simple diffusion across the plasma membrane. 
Inside enterocyte fatty acids and 2-monoglycerides are used for the synthesis of 
triglycerides and packaged with cholesterol, lipoproteins, and other lipids into particles 
called chylomicrons. They are transported first into lymphatic vessels and after that into 
blood vessels (Kong and Singh 2008, Boland, Golding et al. 2014).  
The process of food digestion is very efficient as reflected in the fact that less than 
10 % of food remains undigested. Among the undigested food, the portion is 
indigestible fibers which together with undigested food move from the small intestine to 
the large intestine. The main process in the large intestine is water reabsorption because 
water is present in the food but also in the gastric and the pancreatic juice which in total 




leads to a few hundred milliliters of liquid in the intestine. This would be tremendous 
water lost if we know that in the human body water is highly conserved. Besides water, 
also, the absorption of minerals such as sodium and potassium occurs. In this part GIT, 
the number of commensal bacteria is huge (greater than 10
14
) and this number is bigger 
than the total cell number in the human body (10
13
) this insight or fact can be 
frightening from the aspect that bacteria are disease-causing (Sender, Fuchs et al. 2016). 
However, the majority of bacteria in the large intestine are not harmful and some are 
even required and beneficial for human health. Some essential nutrients like short-chain 
fatty acids, vitamin K and B12 are synthesized by the commensal bacteria in the large 
intestine from the undigested food and fibers (Koh, De Vadder et al. 2016).  
2.3.1. Enzymes involved in food digestion 
The food digestive process is impossible without the different enzymes which are 
spatially distributed. Different parts of the human digestive system are characterized by 
their specific cocktail of enzymes which operate at different optimal pH range. In the 
saliva (pH 7.2) the main digestive enzyme is α-amylase whose systematic name is 1,4-
alpha-D-glucan glucohydrolase. It catalyzes the rapid hydrolysis of 1,4-alpha-D-
glucosidic bonds when the next bond in the sequence is 1,6. There are six isoforms of 
this enzyme, which the optimal pH range is around 7. Starch is a natural substrate of this 
enzyme that hydrolyzes into maltose, maltotriose, maltotetrose, and some higher 
oligosaccharides by the action of this enzyme. (Zakowski and Bruns 1985) Another 
digestive enzyme found in the saliva is lingual lipase, present in very low levels and 
secreted by the glands of von Ebner located in the human tongue. Lingual lipase was 
first detected in the rat and it seems that in humans its role in fat digestion is not so 
important as in rat (Dawes, Pedersen et al. 2015). 
Besides the lingual, a more potent gastric lipase is secreted in the gut. The main 
enzymes secreted in the stomach are pepsin, which will be discussed later and already 
mentioned gastric lipase. The main feature of gastric enzymes is the retention of their 
activity in the acidic environment at pH 2 which classifies them as an extremophile. 
Gastric lipase is involved in the gastrointestinal lipolysis of dietary fat, catalyzes the 
hydrolysis of triacylglycerols to free fatty acids, diacylglycerol, monoacylglycerol, and 
glycerol, and shows preferential hydrolysis at the sn-3 position of triacylglycerol. It is 




secreted by the gastric chief cells in the mucosa of the stomach. For its activity, it does 
not require cofactors like the pancreatic lipase (Aloulou and Carrière 2008, Nomura and 
Casida 2016).  
Pancreatic juice is rich with digestive enzymes like trypsin, chymotrypsin, 
carboxypeptidase, elastase, pancreatic lipase, sterol esterase, phospholipase, several 
nucleases, and pancreatic amylase. Trypsin is a digestive enzyme secreted in the 
pancreas in an inactive form (zymogen) as trypsinogen to prevent enzyme activation in 
the pancreas. In the small intestine, trypsinogen is cleaved by the enteropeptidase from 
the intestinal mucosa into the active form trypsin. Furthermore, trypsin itself can cleave 
more trypsinogen and this process is the so-called autoactivation. Trypsin is a serine 
protease responsible for the cleavage of the protein peptide bonds at the carboxyl end of 
the amino acids lysine and arginine. This process is crucial for the absorption of dietary 
proteins because large proteins are broken down into smaller peptides which can further 
be degraded to amino acids by the action of other proteases and peptidases (Voet and 
Voet 2011). Chymotrypsin is also a serine protease active in the small intestine 
produced in the pancreas as a zymogen chymotrypsinogen. In the small intestine, 
trypsin cleaves chymotrypsinogen into its active form chymotrypsin. Chymotrypsin 
preferentially cleaves peptide amide bonds in which the N-terminal amino acid is 
tryptophan, tyrosine, phenylalanine, or leucine. Carboxypeptidase unlike trypsin and 
chymotrypsin catalyzes the hydrolysis of the peptide bonds at the carboxy-terminal (C-
terminal) end of the proteins or peptides. There are several types of carboxypeptidases 
classified according to their active site mechanism and substrate preference. 
Carboxypeptidase A (A-aromatic, aliphatic amino acids) which cleaves peptide bonds 
of amino acids containing aromatic or branched hydrocarbon chains is present in the 
small intestine. It is also produced in the pancreas in the zymogen form, 
procarboxypeptidase, and it is activated in the small intestine by trypsin cleavage. There 
are two isoforms of carboxypeptidase, A1 and A2. Another pancreatic carboxypeptidase 
is carboxypeptidase B (B-basic) that cleaves peptide bonds of positively charged amino 
acids (arginine, lysine). (Laethem, Blumenkopf et al. 1996) Elastase is another serine 
protease that breaks elastin a fiber which together with collagen makes the connective 
tissue. Also, elastase cleaves the specific peptide bonds on the carboxyl side of small, 
hydrophobic amino acids such as glycine, alanine, and valine. Pancreatic lipase 




(pancreatic triacylglycerol lipase or steapsin) hydrolyzes dietary fats in the human 
digestive system. It converts triglyceride substrates from the ingested fats and oils to 
monoglycerides and free fatty acids. Together with bile acids, pancreatic lipase is the 
main digestive enzyme responsible for lipid digestion, lipids are first emulsified by bile 
salts and then broken down by the lipase. Interestingly, unlike pancreatic proteases, 
lipase is secreted in its already active form but for its activity requires the presence of 
another enzyme colipase. The resulting free fatty acids and monoglycerides are moved 
along the small intestine and absorbed from enterocytes into the lymphatic system by a 
specialized vessel called the lacteal (Pandol 2010). The initial metabolic transformation 
of dietary cholesterol and its esters is catalyzed by sterol esterases. The cholesterol 
esterase from pancreatic juice catalyzes the hydrolysis of cholesterol esters to free 
sterol, which is the form required for absorption in the intestinal lumen. Further, the 
sterol is re-esterified by mucosal sterol esterase before absorption into the lymphatic 
system. (Hyun, Kothari et al. 1969) Phospholipases are enzymes that catalyze the 
hydrolysis of the phospholipids from the dietary fats into free fatty acids and hydro-, 
lipophilic substances. According to the position of bond in phospholipid which catalyze 
they are divided into four classes A (subclasses A1 and A2), B, C, and D. Pancreatic 
phospholipase A2 is secreted as a zymogen, pro-phospholipase A2, and it is activated in 
the small intestine by trypsin cleavage (Gudgeon, Patel et al. 1991).  Nucleases catalyze 
the cleavage of the phosphodiester bonds between the nucleotides of nucleic acids. 
According to the regions of the nucleic acids which they cleave they, are divided into 
endonucleases, which act on the middle regions, and exonucleases, which act on the end 
of the target molecule (Whitcomb and Lowe 2007). 
2.3.1.1. Pepsin  
Pepsin is a proteinase secreted by the chief cells of the human gastric mucosa. Inside 
the chief cells, the enzyme is stored in granules as inactive zymogens. In the stomach, 
zymogen-pepsinogen is activated by low pH below 4.5 but it is easily inactivated by pH 
above 7.0. Unlike pepsin, pepsinogen contains 44 additional amino acid residues which 
“cover” the enzyme’s active site and prevent premature enzyme activation. The low pH 
value (around pH 2) in the stomach causes removal of the additional amino acids which 
leads to alteration of the protein structure, so the enzyme’s active site becomes 




uncovered and available to bind substrate. Besides this, for the protein to be active, one 
of the two aspartate residues in the catalytic site has to be protonated (Asp 215), and the 
other deprotonated (Asp32). This occurs between pH 1 and 5, so this is the optimal pH 
range of pepsin activity. Because pepsin has two aspartate residues in the active site it 
belongs to the family of aspartic protease. Pepsin is a monomer composed of two 
domains. It has 326 amino acid residues with a high percentage of acidic residues and 
has a molecular weight of 34.6 kDa. The secondary structure predominates beta-sheet 
but also has a limited number of alpha-helices. There are four reported pepsin proteins: 
pepsin A (the predominant gastric protease) and minor forms, pepsin B (parapepsin I), 
C (gastricsin), and D (an unphosphorylated version of pepsin A) (Lee and Ryle 1967). 
Pepsins B and C share a higher degree of homology (Narita, Oda et al. 2002). The 
reaction mechanism of pepsin catalysis is shown in Figure 8. In the first step of the 
reaction oxygen from the water, the molecule performs the nucleophilic attack on the 
carbonyl carbon on the substrate. This attack of a water molecule on the peptide bond is 
facilitated by the attack of deprotonated Asp32 on the water proton whereby oxygen 
becomes a stronger nucleophile. At the same time, the oxygen of the carbonyl group 
attacks the proton Asp215, which is protonated, which leads to the formation of a 
transition state. In the transition Asp32 is protonated, Asp215 deprotonated and the 
substrate is in the amid dihydrate form. In the next step, there is proton transfer from the 
Asp residue to the nitrogen of amide bond and from the hydroxyl group of carbonyl 
carbon to the Asp residue as well as rearrangement of electrons in the peptide bond 
which leads to its cleavage (Garrett and Grisham 1999). 
Figure 8. Pepsin reaction mechanism.
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2.4. Food Allergies  
The adverse reactions to food (Figure 9) can be immune-mediated, non-immune 
mediated, and toxic. Immune-mediated reactions can be divided into food allergy and 
coeliac disease (Turnbull, Adams et al. 2015). Food allergies represent an emerging 
health problem especially in the developing countries and within the young children 
population. There is no precise information about its prevalence but it could be stated 
that ‘‘food allergy affects more than 1 to 2% but less than 10% of the population’’. The 
most common allergens in children are cow’s milk (2.2%), peanut (1.8%), and tree nuts 
(1.7%), while the most common allergens in adults are shellfish (1.9%), fruits (1.6%), 
and vegetables (1.3%) (Sicherer and Sampson 2014). 
 




In food allergies, the immune response can be IgE-mediated, non-IgE-mediated, or a 
mixture of both. During IgE-mediated food allergies the first step is the phase of 
allergen sensitization when specific IgE antibody to food allergen secrets into the 
serum. In the second phase or the effector phase, symptoms and signs of food allergy 
occur after the exposure to the food allergen. Non-IgE-mediated food allergies are 
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characterized mostly by T cell-mediated processes. The third type of food allergies is 
mixed IgE and non-IgE-mediated food allergy such as eosinophilic inflammation of 
GIT (Turnbull, Adams et al. 2015). 
Sensitization to food allergens occurs in the GIT and oral cavity and those are well-
known routes which include class 1 or oral allergens such as milk, egg, or peanut. 
Another sensitization route is via respiratory tract which includes class 2 food allergens 
or aeroallergens such as the major birch pollen allergen Bet v 1. The immune responses 
to class 2 food allergens cross-react with homologous food allergens, such as the major 
apple allergen Mal d 1, and cause oral allergy syndrome. (Valenta, Hochwallner et al. 
2015) Furthermore, it is proposed that the third route of sensitization to food allergens 
(e.g. peanut) is via skin contact, but still, there is an ongoing research of this process 
(Asero and Antonicelli 2011). During food ingestion in the stomach and intestine 
proteins from food are digested to peptides by digestive enzymes at appropriate pH 
levels. However, the remaining intact food proteins and large peptides are capable of 
reaching the intestinal cells and as such transported from the lumen of the gut to the 
mucosa by the epithelial cells, M cells localized above the Peyer’s patches or by 
mucosal DCs which extend their dendrites into the gut lumen (Sampson, O'Mahony et 
al. 2018).  
It is well known that the largest secondary lymphoid organ in the human body is gut-
associated intestinal lymphoid tissue. This is understandable because, from the one side, 
ingested antigens are constantly sampled and recognized as harmful or non-harmful by 
the immune cells of GIT but from the other side some antigens like commensal bacteria 
must be actively ignored by these cells. All this explains the complexity of intestinal 
lymphoid tissue as well as the regulatory processes occurring within this tissue  
(Nowak-Wegrzyn, Szajewska et al. 2017).  
To establish and maintain a physiological immune response, it is important to 
establish tolerance to food proteins transported through the epithelium in the absence of 
other dangerous signals. Currently, scientists show great interest in the understanding 
mechanism of establishing tolerance. The study on mice showed that the population of 
CD103
+
 DCs after the uptake of food antigens in the gut migrates to the lymph nodes to 
“educate” the naïve T cells (Figure 10a). The characteristic of CD103
+
 DCs is the 




induction of Treg cells (Iwata, Hirakiyama et al. 2004, Coombes, Siddiqui et al. 2007). 
Also, CD103
+
 DCs express aldehyde dehydrogenase which enables the metabolism of 
vitamin A to retinoic acid, which is important in the regulation of T cells. T-cells 
possess the retinoic acid receptor and its interaction with retinoic acid induces the 
expression of the gut-homing receptor α4β7 and  FOXP3, the master transcription factor 
responsible for inducing and maintaining a Treg phenotype (Elias, Laurence et al. 
2008). It was shown that ανβ8 integrin expressed on DCs generate the signal which 
causes the release of immunosuppressive TGFβ which is involved in the further Treg 
cell induction (Worthington, Czajkowska et al. 2011). According to all above mention, 
in the GIT there is a very complex interplay between DCs and T-cells. 
The food antigens which reach the bloodstream enter the portal circulation and pass 
through the liver where again encounters the tolerogenic populations of APCs, the 
resident macrophages (Kupffer cells), and liver sinusoidal endothelial cells. This 
process is very important for the explanation of an unusually high rate of new-onset 
food allergy in the individuals with liver-transplantation because there is a mismatch 
between MHC on their T cells and MHC on the liver allograft (Boyle, Hardikar et al. 
2005, Brown, Haringman et al. 2012, Renz, Allen et al. 2018). 
 
Figure 10. Establishing of immune tolerance to ingested antigens and tolerance 
breakdown.
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The established tolerance to food antigens can be broken and induction of Treg cells 
by CD103
+
 DCs can be shifted to the generation of proallergic Th2 effector cells 
(Figure 10b). The factors which induce the brake of tolerance are various and poorly 
understood. It is considered that pathogen-associated molecular patterns (PAMPs), 
products of commensal and pathogen microorganisms, induce injury of the intestinal 
epithelium but also antigens exposure at other sites, like skin, are the main culprits. The 
key proallergic cytokine is IL-4, it is produced by the Th2 cell population upon 
exposure to food allergens. IL-4 further drives IgE switching in B cells and influences 
mast cell survival and tissue sensitivity to mast cell mediators. (Renz, Allen et al. 2018). 
Also, the gut epithelial cytokines induce expansion of Th2 innate cells which produce 
IL-4 and IL-13 cytokines that block Treg cell function (Blázquez and Berin 2008). 
Another important impact arises from the allergen-specific IgE antibodies which 
activate mast cells via FcεRI and activated mast cells to generate IL-4 which further 
promotes Th2 cell induction and suppresses Treg cell induction, this is known as the 
positive feedback loop (Burton, Noval Rivas et al. 2014). Interestingly, Treg cells can 
be reprogramed towards the Th2 phenotype to produce IL-4 while maintaining 
expression of FOXP3
+
 (Noval Rivas, Burton et al. 2015). Beside the intestine, there are 
other routes and causes of tolerance breakdown. For example, children who have food 
allergy often have atopic dermatitis and food allergens may enter through scratched and 
inflamed skin and induce the breakdown of tolerance in the intestine (Brough, Liu et al. 
2015). Another example of tolerance breakdown is the oral allergy syndrome in which 
IgE antibodies are generated in response to some inhaled aeroallergens cross-react with 
food allergens. Hypersensitivity to latex can also induce sensitivity to food such as 
banana, avocado, and kiwifruit (Webber and England 2010).  
2.4.1. Red meat allergy 
The intriguing story of mammalian red meat allergy begun recently in 2007, when 
Van Nunen (2009) reported that individuals who had been bitten by ticks experienced 
urticarial or anaphylactic reactions after ingestion of red meat. A few years later 
Commins (2009) reported anaphylactic and urticarial reactions in individuals who 
consumed red meat and previously reported large local reactions to a tick bite. (Levin, 
Apostolovic et al. 2019) The most important in elucidating the causative agent of red 




meat allergy was cetuximab, a chimeric mouse-human monoclonal antibody against the 
epidermal growth factor receptor, used for the treatment of patients with colorectal 
cancer. It was discovered that these patients have a high titer of IgE antibodies reactive 
toward the galactosyl-α-1,3-galactose (α-Gal). In cetuximab, α-Gal is present on 2 N-
linked oligosaccharide domains on the Fab portion of the cetuximab heavy chain (Qian, 
Liu et al. 2007, Chung, Mirakhur et al. 2008). Allergic reactions to red meat have been 
reported in many other countries besides Australia and the USA, such as Sweden, 
Germany, France, Spain, Japan, and Africa (Jacquenet, Moneret-Vautrin et al. 2009, 
Commins, Kelly et al. 2012, Jappe 2012, Sekiya, Fukutomi et al. 2012, Hamsten, Tran 
et al. 2013). The symptoms of red meat allergy are various, ranging from urticaria, 
angioedema, and the most severe allergic reaction, anaphylaxis (Kiewiet, Apostolovic et 
al. 2020). Recent findings suggest that abdominal pain is a frequent but often 
underreported symptom (Commins, Satinover et al. 2009, Mabelane, Botha et al. 2018). 
One more interesting fact about the red meat allergy is the delayed onset of symptoms, 
usually 3 to 6 hours after the red meat consumption, but according to some reports, 
symptoms could also appear within 2 hours (Commins and Platts-Mills 2009, Mabelane, 
Botha et al. 2018). There seems to be some link between reactions to cetuximab and red 
meat allergy in areas of high prevalence of the lone star tick, Amblyomma americanum. 
It is believed that tick bites are an important cause of sensitization to α-Gal. This 
epitope is found in the content of gastrointestinal tract and/or saliva of different species 
of tick such as Ixodus ricinus, Amblyomma sculptum, Heamaphysalis longicornis, and 
Ixodes scapularis (Hamsten, Starkhammar et al. 2013, Araujo, Franco et al. 2016, 
Chinuki, Ishiwata et al. 2016, Cabezas-Cruz, Espinosa et al. 2018). Moreover, 
intradermal injection of tick salivary gland extract from A. americanum induced 
sensitization to α-Gal and allergic responses upon ingestion of pork sausage in the 
murine model of α-Gal allergy (Commins and Karim 2017).  
The concentration and the total amount of α-Gal present in different foods varies but 
it is the most abundant in the food derived from the animal's internal organs (Morisset, 
Richard et al. 2012, Apostolovic, Tran et al. 2014). Interestingly some of the identified 
α‐Gal‐containing IgE‐binding proteins, such as creatine kinase M‐type, aspartate 
aminotransferase, alpha- and beta-enolase were stable to heat treatment (Apostolovic, 
Tran et al. 2014). Also, it seems that lipids present in meat influence the severity of 




symptoms as consumption of meat with higher lipid content induced more severe 
symptoms in allergic individuals (Steinke, Pochan et al. 2016). Moreover, some 
cofactors can influence and induce more severe symptoms even after the ingestion of 
food with a very low content of α-Gal. The identified cofactors are exercise, 
nonsteroidal analgesics, and alcohol (Fischer, Eberlein et al. 2017). The cause of the 
delayed onset of symptoms and the cofactor mechanism of action is still unknown and 
bioavailability and presentation of cofactors and allergen to immune cells can be one of 
the explanations. 
 Also, the prevalence of red meat allergy is higher in middle-aged individuals 
compare to young people, probably because they spend more time in nature and are 
more exposed to tick bites. Interestingly, in the earliest reports, a higher prevalence of 
red meat allergy was noted in the male population than in the female population. This 
observation was attributed to the higher environmental exposure of males regarding 
their profession, but with the emerging data, a clear line between the frequency of red 
meat allergy between men and women cannot be drawn (Commins, James et al. 2011, 
Commins, James et al. 2014, Kiewiet, Apostolovic et al. 2020). 
2.4.1.1. Alpha-Gal epitope structure and recognition  
Alpha-Gal consists of two molecules of galactose linked by an α-1,3-glycosidic 
bond and it is the main recognition domain of α-Gal epitope which contains three 
carbohydrate residues (Galα1-3Galβ1-4GlcNAc-R) (Figure 11). The alpha-Gal epitope 
is found on proteins and lipids of non-primate mammals. The synthesis of the α-Gal 
epitope is catalyzed by different enzymes, but in the last step, the enzyme α-1,3-
galactosyltransferase (α1,3GT) catalyzes the formation of the α-1,3-glycosidic bond 
between two Gal residues. It is found that humans, apes, and Old World monkeys have 
α1,3GT pseudogene on chromosome 9 instead of the normal gene present in non-
primate mammals. It is thought that inactivation of this enzyme has occurred 28 million 
years ago when two point mutations (deletion) happened in the exon that codes the main 
catalytic domain of the enzyme which causes a frameshift and a premature stop codon 
(Larsen, Rivera-Marrero et al. 1990). The lower mammals possess α-Gal as a post-
translational modification while humans do not, so this is a reason why they produce α-
Gal antibodies (Commins 2015).  





Figure 11. The structural formula of the α-Gal epitope and α-Gal residue. 
There are obvious structural similarities among α-Gal and the blood group B-
antigen, with B-antigen possessing an extra fucose residue on the glycan core. Because 
of this, in the individuals with B or AB blood group, the levels of IgE and IgG against 
α-Gal are measured. The obtained results showed that healthy individuals have almost 
the non-existing level of IgE and low level of IgG antibodies to α-Gal. The connection 
between the levels of IgG and IgE antibodies was found, thus in patients with higher 
IgE levels proportionally higher level of IgG1 was found when compared to the 
background level of IgG2 specific for α-Gal. These findings suggest that in the normal 
physiological conditions the low level of IgG2 present probably an immune response 
against the α-Gal epitope expressed on normal gut bacterial flora. During the immune 
response to the α-Gal sensitization by Th2 cells elevated levels of IgE, and IgG1 are 
generated in addition to the existing IgG2 (Oostingh, Davies et al. 2003, Rispens, 
Derksen et al. 2013). Importantly, the immune response to α-Gal and B-antigen differs 
among red meat allergic patients and healthy individuals. The immune response to α-
Gal in red meat allergic patients is characterized by increased levels of IgE, IgG1, and 




IgG4, while the response to the B-antigen is characterized by increased levels of IgG2 
(Apostolovic, Rodrigues et al. 2018). 
Production of anti-α-Gal antibodies is a response to continuous antigenic stimulation 
by carbohydrate antigens on GI bacteria of the normal flora (Galili, Mandrell et al. 
1988) similar to the production of antibodies to the blood group A and B carbohydrate 
antigens (Springer and Horton 1969). It was shown that anti-α-Gal antibodies are 
capable to differentiate structures with variations in the linkage positions of the terminal 
galactose residues but have the same carbohydrate sequence and anomerity (Galili, 
Macher et al. 1985). The hydrogen bonds, hydrophobic interactions, and van der Waals’ 
forces are responsible for the binding of anti-α-Gal antibodies to the α-Gal epitopes. 
These forces are of short distance and require closer interaction and more precise 
orientation such as the case for the hydrogen bonds which are the main interaction, in 
this case, compare to ionic bonds between charged amino acids on the binding surface 
of the antibodies and protein allergens (Commins 2015). 
2.5. Development and use of in vitro systems for studies of physiological 
processes such as bioavailability and uptake by immune cells 
The use of in vitro models is required during the experimental study of complex 
processes such as food digestion, the release of food nutrients, and their bioavailability. 
In the past two decades, a lot of effort has been put into developing these models but 
still, there is not a complete, model that describes in detail all these processes in the 
organism. Hence, some models mimic conditions in the mouth, stomach, and the small 
intestine, the so-called digestion models, and those which serve for monitoring the 
transport of the nutrients and allergens across the intestinal barrier or for monitoring the 
uptake of allergens by the GIT immune cells. Existing in vitro digestion models can be 
firstly classified as the static or dynamic models and secondly as a monocompartmental, 
bicompartmental, or multicompartmental model (Guerra, Etienne-Mesmin et al. 2012).  
In the literature different in vitro, static models are applied depending on the starting 
material such as whole meal, proteins, carbohydrates, etc. For example one of the static 
digestion models is developed by Moreno and coworkers for analysis of allergen 2S 
albumin (Ber e 1) (Moreno, Mellon et al. 2005). The same protocol with slight 




modifications is used for the analysis of bovine thyroglobulin, protein carrying α-Gal 
epitope (Apostolovic, Krstic et al. 2017).  
Static digestion models are widely used in the research laboratory setting. In these 
models, the gastric phase encompasses hydrolysis of the homogenized food or protein 
of interest, usually allergen, by pepsin under given conditions such as pH and 
temperature and for a set period. Usually, the given conditions are pH 1-3 temperature 
37 ˚  and the duration of digestion is usually 1 to 4 hours. The gastric phase of 
digestion can be stopped after a predetermined time and obtained so-called “digesta” 
can be examined and characterized, or followed by the intestinal phase of digestion. 
During this phase of digestion in the same vessel enzymes with or without bile 
characteristics for intestinal digestion are added and pH raised to 6 or 7.  Besides 
enzymes, bile can be added in this phase of digestion depending on the starting material 
used for the analysis (Hur, Lim et al. 2011).  
Just a brief look at the literature indicates the diversity of digestion protocols used in 
the research and this is the starting point for developing a unique protocol that would be 
used in laboratories to make the obtained results comparable. Such is initiative is 
proposed by the COST Infogest network in the form of a consensus paper where a 
general standardized and practical static digestion model was described (Figure 12) 
(Minekus, Alminger et al. 2014). Although Infogest’s statistic digestion model is mostly 
for the “whole meal situation” it can be easily applied to a single protein/allergen. 
However, the statistic in vitro models has its weaknesses such as no good replacement 
for the complex peristaltic movements, gastric emptying, and continuous changes in the 
pH and secretion flow rates. To overcome these dynamic models are developed such as 
dynamic monocompartmental models (Hoebler, Lecannu et al. 2002), dynamic 
bicompartmental models (Mainville, Arcand et al. 2005), and multicompartmental 
models (Minekus, Marteau et al. 1995).  





Figure 12. Flow diagram of a simulated in vitro digestion method by Minekus and 
coworkers. SSF-Simulated Salivary Fluid, SGF-Simulated Gastric Fluid, and SIF-
Simulated Intestinal. Enzyme activities are in units per mL of the final digestion mixture 
at each corresponding digestion phase.
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 The cell-based models for monitoring of transport of food proteins and/or 
allergens as well as other nutrients, and very important drugs are widely used. These 
experimental models are crucial in the initial phase of the clinical trials and to help to 
reduce animal experimentation. Caco-2 cells (cancer cell line), which mimic the 
intestinal epithelial cells and forming the intestinal-like barrier under certain growing 
conditions, are a gold standard model for evaluation of transport through the intestinal 
epithelium (Hubatsch, Ragnarsson et al. 2007). Their phenotype is well characterized 
and they are widely used for the analyses of drug transport (Sun, Chow et al. 2008)  or 
transport of food allergens (Moreno, Rubio et al. 2006, Thierry, Bernasconi et al. 2009, 
Price, Ackland et al. 2014). Another cancer cell line widely used in “gut-mimicking” 
experiments is T-84 (Raffatellu, Wilson et al. 2005, Tran, Gomez et al. 2009). The main 
characteristic of these two cancer cell lines is forming polarized monolayer and 
exhibition of microvilli formation. Also for transport experiments these cells are 
commonly grown on semi-permeable Transwell® inserts. Beside tremendous 
advantages in the first place easy maintenance, cultivation, and reproducibility, these 
cell-based model system have some limitations. It is primarily a lack of mucus-secreting 
goblet cells in the intestinal-like barrier as well as the expression of different 
transporters and metabolic proteins depending on the applied culture conditions. To 
overcome some of these obstacles recently the primary human intestinal epithelial cells 
(hInEpCs) have become recently commercially available. As these cells are more 
difficult to handle, there is only a limited amount of data based on these cells 
(Kauffman, Gyurdieva et al. 2013). Also, the hInEpCs line is the basis for the 
development of novel, in vivo-like organoid molecules. The organoids represent the 
respective native organs in their structure and function features. For this purpose adult 
intestinal stem cells are directly isolated from human biopsies and this system can be 
maintained even for several months without significant phenotype changes (Sato, Vries 








3. Aims  
 
Within this doctoral dissertation, several aims have been formulated: 
 
a) To examine the effect of the α-Gal epitope on the protein surface with respect to 
susceptibility to gastric digestion in the pepsin in vitro digestion model.  
 
b) To examine the effect of the α-Gal epitope on protein transport through the 
monolayer of Caco-2 cells, a model system of the intestinal epithelium. 
 
c) To examine the effect of the α-Gal epitope on protein uptake and processing in the 
















4. Pepsin digestion pattern of α-Gal glycosylated bovine serum 
albumin  
4.1. Introduction 
Although in recent years resistance to gastrointestinal digestion of food allergens as 
one of the markers of allergenicity was questioned it is still an inevitable tool in 
assessing the allergenicity, especially for novel food allergens (Bøgh and Madsen 
2016). According to our knowledge, there is a lack of data in the literature on the 
digestibility of proteins carrying the α-Gal epitope. Also, it is very hard to compare 
results obtained in different studies dealing with resistance to gastrointestinal digestion 
since different in vitro digestion protocols have been applied. To avoid these obstacles 
Minekus and coworkers (Minekus, Alminger et al. 2014) proposed a consensus model 
for simulated in vitro gastrointestinal digestion which was primarily intended for whole 
meal digestion simulation but can also be applied to individual proteins/allergens.  
The α-Gal-containing proteins from different beef preparations (raw, medium rare, 
fried, and boiled beef) have been identified and their potential allergenicity was 
investigated by monitoring the binding of IgE antibodies from meat-allergic patients 
(Apostolovic, Tran et al. 2014). Although various α-Gal carrying proteins have been 
identified little is known about their bioaccessibility during gastrointestinal digestion.  
This is important especially in terms of the food matrix which can have a tremendous 
impact on the bioaccessibility of proteins from food  (Vissers Y.M., Wichers H.J. et al. 
2012). Besides α-Gal caring protein, protein without this epitope or deglycosylated 
protein is required for an in-depth investigation of the influence of α-Gal epitope on 
protein resistance to digestion and pattern of the released digestion peptides.  
Bovine thyroglobulin (bTG) is a naturally occurring protein that possess α-Gal 
epitope as a posttranslational modification and it is abundantly present in red meat 
(Rawitch, Pollock et al. 1993). Apostolovic, Krstic et al. (2017) performed the 
simulated in vitro gastrointestinal digestion of bTG using protocols recommended by 
Moreno, Mellon et al. (2005) and Koppelman, Hefle et al. (2010) and found that α-Gal 
peptides were present during the whole gastric phase of protein digestion. It was also 
confirmed that there was not IgE binding to digested peptides if they were 




deglycosylated. Besides this, another important finding was that at the acidic pH 
conditions deglycosylated bTG was insoluble which makes gastric digestion impossible 
and thus limiting the use of the deglycosylated bTG as the α-Gal negative control 
(Apostolovic, Krstic et al. 2017).  
As previously mentioned studies dealing with the gastrointestinal digestion of 
red meat as well as individual α-Gal-containing proteins are highly needed. Also, it is 
very important in the research that some consensus models be adopted and followed in 
conducting in vitro studies of bioaccessibility of food proteins and simulated 
gastrointestinal digestion of individual proteins/allergens. Taking into account 
previously mentioned one of the aims of this doctoral dissertation was to check the 
usability of the simulated in vitro pepsin digestion for the monitoring digestion of α-Gal 
containing food allergens using α-Gal glycosylated bovine serum albumin (BSA-α-Gal), 
as a model protein. 
4.2. Methodology 
4.2.1.  Reagents  
Used proteins were commercially available. BSA and pepsin were obtained from 
Sigma-Aldrich (Merck, Steinheim, Germany). α-Gal glycosylated BSA (BSA-α-Gal) 
and N-Acetyllactosamine conjugated BSA (BSA-NAl) were obtained from Dextra 
Laboratories (Reading, UK). Other chemicals used in the experiments were p.a. grade 
and obtained from Sigma-Aldrich unless stated otherwise. 
4.2.2.  Protein sample preparation 
Used proteins were fluorescently labeled by conjugating AlexaFluor488 (AF488) 
fluorescent dye using an AF488 protein labeling kit (Invitrogen, Molecular Probes, Inc., 
Eugene, Oregon, USA) according to the manufacturer’s instructions. For determination 
of protein concentration commercial kit Pierce Bicinchoninic acid (BCA) Protein Assay 
Kit (Pierce Biotechnology, Rockford, Illinois, USA) was used. 




4.2.3.  In vitro gastric digestion 
“For in vitro gastric digestion the statistic digestion model proposed by Minekus, 
Alminger et al. (2014) was used with slight modification. The carbohydrate conjugated 
proteins BSA-α-Gal, BSA-NAl, and unconjugated BSA fluorescently labeled with 
AF488 were pre-incubated at 37 °C for 15 min before pepsin in simulated gastric fluid 
(SGF) was added in a 1:3 (volume protein/volume SGF with pepsin) ratio. In vitro 
digestion protocol was adjusted to single protein digestion so the final enzyme activity 
was 8 U pepsin per mg of protein. The recipe and calculation for the preparation of 4 × 
SGF are presented in Table 1. The pH of the digestion mixture was adjusted to 3 by the 
addition of 1 M HCl. Simulated gastric digestion was monitored for up to 4 h at 37 °C, 
and aliquots were withdrawn from a single digestion mixture at different time points for 
further analysis. The digestion was stopped by raising the pH of the digestion mixture to 
7.5 by adding 1 M NaHCO3.” (Krstic Ristivojevic M., Grundström J. et al. 2020) 
Table 1. Preparation of stock solution of simulated gastric fluid (SGF). The masses 
of substances are calculated to prepare 200 mL 4 × concentrate SGF solution. 
SGF pH 3 
Constituent 4 × SGF* Final conc. in 
SGF 
 g mmol/L 
KCl 0.41 6.90 
KH2PO4 0.10 0.90 
NaHCO3 1.68 25.00 
NaCl 2.21 47.20 
MgCl2(H2O)6 0.02 0.10 
(NH4)2CO3 0.08 0.50 
CaCl2(H2O)2 0.02 0.15 




HCl 1.04 15.6 
*to prepare 200 mL of 4 × SGF solution 
a 
molarity of a stock solution 
 




4.2.4.  SDS PAGE analysis  
For analysis of digestion products of BSA with or without glycosylation sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS PAGE) according to Laemmli 
(1970) under reducing conditions was performed. The digestion products of BSA with 
or without glycosylation were resolved on the 14% polyacrylamide (PAA) hand-cast 
gels and analysis were carried out using a Hoefer Scientific Instruments apparatus 
(Holliston, Massachusetts, USA) with a discontinuous buffer system. The resolved PAA 
gels were stained using Coomassie Brilliant Blue R-250 and scanned using the Typhoon 
FLA 7000 laser scanner (GE Healthcare, Freiburg, Germany). 
4.2.5. Immunoblot for detection of the BSA and α-Gal epitope 
“Bovine serum albumin and α-Gal in BSA-α-Gal digests were detected by 
immunoblot analysis. Previously resolved proteins by SDS PAGE were transferred to 
polyvinylidene difluoride (PVDF) membranes (0.2 µm pore size) using an EBU-4000 
Semi-Dry Blotting System (Fisher Scientific Company L.L.C., Pittsburgh, 
Pennsylvania, USA). For the immunodetection of in vitro pepsin-digests, peptides of 
BSA-α-Gal, BSA-NAl, and BSA the membranes were probed with the rabbit polyclonal 
anti-BSA IgG antibody (Invitrogen, A11133) diluted 1:1000 in 0.1% human serum 
albumin (HSA) for 1.5 h at room temperature (RT) followed by goat anti-rabbit IgG 
conjugated to alkaline phosphatase (AP) (ab97072, Abcam, Cambridge, Massachusetts, 
USAab97072) diluted 1:5000 in 0.1% HSA for 1 h at RT. Immunoreactive bands were 
visualized using nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) substrates. For the immunodetection of α-Gal on peptides of BSA-α-
Gal obtained upon simulated in vitro digestion the membranes were probed with 
monoclonal mouse anti-α-Gal antibody M86 (Enzo Life Sciences, Farmingdale, New 
York, USA) diluted 1:5 in 0.1% HSA in Tris-buffered saline – Tween 20 (TBS-T) for 3 
h followed by AP-labeled goat anti-mouse IgM antibody (Southern Biotech, 
Birmingham, Alabama, USA) diluted 1:3000 in TBS-T for 1 h at room RT. Reactive 
bands were visualized as stated above.” (Krstic Ristivojevic M., Grundström J. et al. 
2020)  




4.3. Results  
4.3.1.  Pepsin digestion pattern of BSA, BSA-α-Gal, and BSA-NAl 
The assessment of the stability of a protein or its proteolytic fragments during 
pepsin digestion is an important parameter in sensitization in food allergy. Hence, it is 
of importance to examine whether the α-Gal glycosylation of BSA has any impact on its 
resistance to pepsin digestion and profile of the proteolytic fragments. In the first 
experiment of this thesis, the difference in molecular weight between molecules of BSA 
before and after glycosylation was checked. The pure proteins, BSA (control) and with 
α-Gal glycosylation (BSA-α-Gal) were separated onto 12 % PAA gel using SDS-PAGE 
(Figure 13). 
 
Figure 13. Fluorescent detection of AF488 labeled BSA and BSA-α-Gal resolved on 
the 12 % PAA gel after SDS-PAGE. 
To examine the influence of glycosylation of BSA on its resistance to pepsin 
digestion, the pepsin digestion profiles of BSA-α-Gal, BSA-NAl and BSA were 
compared using SDS PAGE under reducing conditions. Obtained gels were analyzed by 
staining with CBB R250 or by immunoblot using a polyclonal anti-BSA antibody 
(Figure 14 and 17). Besides this, to investigate the content of the α-Gal epitope on the 
released peptides during digestion of BSA-α-Gal by pepsin, the obtained gel was 
additionally analyzed by immunoblot using mouse monoclonal anti-α-Gal antibody 
M86 (Figure 16). To eliminate the additional bands in the digestion profiles of analyzed 
BSA which can be originated from pepsin during its auto-digestion or the presence of 




impurities, a sample of pure pepsin was also analyzed at 0 and 4 h from the beginning of 
digestion (Figure 15).  
 
Figure 14. In vitro gastric digestion products of BSA and BSA-α-Gal obtained during 4 
h of digestion, resolved on SDS PAGE, and analyzed by staining with CBB R-250 (A) 
and (C), or by immunoblot with polyclonal anti-BSA antibody (B) and (D). 2°Ab = 
control of unspecific binding of the secondary antibody, MW = Molecular weight 
markers, and CTRL = undigested protein. 
 
Figure 15. SDS-PAGE analysis of pepsin control solution at 0 and 4 h time point of 
digestion, stained by CBB R-250. MW = Molecular weight markers. 
From the presented results it can be seen that intact BSA and BSA-α-Gal can be 
detected up to 15 min of digestion (Figure 14B and D) and that the degradation pattern 




of BSA and BSA-α-Gal are different. Interestingly, BSA and BSA-α-Gal degraded 
promptly, even after 15 s of digestion peptides of about 45 kDa for BSA and 55 kDa for 
BSA-α-Gal appeared and became more intense when digestion was prolonged up to 5 
min. The important finding was that the pepsin digestion products of BSA-α-Gal with 
MW ranging between 25 and 55 kDa were present for up to 2 h of digestion. On the 
other hand, similar-sized pepsin digestion products of BSA were only detected up to 30 
min of digestion. Also, another difference between digestion patterns was that BSA 
digestion peptides of the MW below 25 kDa were distinct bands whereas BSA-α-Gal 
digestion peptides below 25 kDa were smeared bands. The obtained results suggest that 
the presence of the α-Gal epitope on the BSA-α-Gal alters the protein susceptibility to 
pepsinolysis. 
According to the obtained results, it can be concluded that the glycosylation of 
BSA with the α-Gal epitope can influence the resistance of BSA-α-Gal to digestion by 
pepsin. To confirm these results, in the next experiment the content of α-Gal epitope on 
the released pepsin digestion fragments obtained during in vitro digestion of BSA-α-Gal 
were determined by immunoblot analysis using mouse monoclonal anti-α-Gal IgM 
antibody (Figure 16).   
 
Figure 16. In vitro gastric digestion products of BSA-α-Gal during 4 h of digestion 
analyzed by immunoblot analysis using mouse monoclonal anti-α-Gal antibody M86. 
2°Ab = control of unspecific binding of the secondary antibody, MW = Molecular 
weight markers, and CTRL = undigested protein. 
In Figure 16 it can be seen that the large α-Gal carrying peptide with the MW of 
approx. 55 kDa appeared after only 15 s of digestion and was still detected, although 




barely, after 2 h of the in vitro pepsin digestion. Also, peptide fragment with MW of 
approx. 45 kDa follows the appearance of the larger previous peptide. Moreover, 
peptide fragments with MW of approx. 37, 32, and 25 kDa carrying α-Gal were detected 
after 1 h. 
 To gain a better insight into the effect of the α-Gal epitope on the pepsin 
digestion of the α-Gal containing proteins we performed in vitro pepsin digestion of 
BSA-NAl, which possesses a carbohydrate modification similar in size to α-Gal (Figure 
17). According to the obtained results presented in Figure 17 this carbohydrate 
modification of BSA has a significant impact on its resistance to pepsinolysis. Intact 
BSA-NAl was still detectable after 15 min of digestion compared to BSA which was, 
although barely, detectable up to 5 min of digestion (Figure 14). On the other hand, 
immunoblot detection using a polyclonal anti-BSA antibody revealed that the intact 
protein was present for up to 2 h of in vitro digestion (Figure 17B). Moreover peptide 
fragments with MW of approx. 55, 45, 37, 32, and 25 kDa were detected even after 4 h 
of in vitro pepsin digestion. 
 
Figure 17. In vitro gastric digestion products of BSA-NAl obtained during 4 hours of 
digestion, resolved on SDS PAGE, and analyzed by staining with CBB R-250 (A), or by 
immunoblot with polyclonal anti-BSA antibody (B). 2°Ab = control of unspecific 
binding of the secondary antibody, MW = Molecular weight markers, and CTRL = 
undigested protein. 
Different systems for detection which are more or less sensitive were used for 
the analysis of obtained peptide fragments during digestion of different BSA molecules 
by pepsin. In Figure 18 the obtained digestion patterns of the AF488 labeled BSA, 
BSA-α-Gal, and BSA-NAl using fluorescent detection are shown. Obtained digestion 
patterns of proteins are in correlation with the results obtained with the above-
mentioned detection systems such as CBB R-250 and immunoblot analysis using a 




chromogenic NBT/BCIP substrate. The intact BSA was visible up to 5 min of 
pepsinolysis while BSA-α-Gal and BSA-NAl were visible up to 15 min of pepsinolysis. 
Also, the presence of the α-Gal epitope on the BSA-α-Gal peptides and NAl on the 
BSA-NAl peptides is the probable reason for the obtained smeared bands whereas BSA 
peptides were distinct on the resolved PAA gels.  
 
Figure 18. In vitro gastric digestion products of (A) BSA, (B) BSA-α-Gal, and (C) 
BSA-NAl obtained during 4 hours of digestion, resolved on SDS PAGE and analyzed 
by fluorescent detection using AF488 fluorescent dye. MW = Molecular weight 
markers, and CTRL = undigested protein. 




4.4. Discussion  
Glycosylation a posttranslational modification of proteins and lipids contributes to 
the complexity of the biological structures available in living organisms. This 
modification is especially important for the proteins which are the key players in a 
broad spectrum of biological processes (Maureen E. Taylor and Drickamer 2011). 
Although carbohydrates as such are mainly not considered as potent inducers of allergic 
reactions, α-Gal carbohydrate proves the opposite. The alpha-Gal epitope is present in 
beef proteins and even food processing such as cooking does not influence its 
allergenicity (Apostolovic, Tran et al. 2014). 
The obtained results demonstrated that the digestion stability of proteins and the 
pattern of the resulting peptides was influenced by protein glycosylation, one of the 
most common posttranslational modifications (Krstic Ristivojevic M., Grundström J. et 
al. 2020). One of the findings is that the type of glycosylation influence the protein 
susceptibility to pepsinolysis, α-Gal glycosylation increased the resistance of BSA to 
pepsinolysis, but NAl glycosylation hampered pepsinolysis even more. “Intact BSA-α-
Gal, similar to BSA, could be detected up to 15 min of in vitro pepsin digestion, 
whereas intact BSA-NAl could be detected for up to 2 h. These findings are following a 
previous study that demonstrated that glycosylation protects the egg white allergen 
ovomucoid from pepsinolysis (Benede, Lopez-Fandino et al. 2013). The major impact 
of protein glycosylation was observed in the digestion patterns of BSA-α-Gal compared 
to BSA, large digestion products of BSA-α-Gal ≥ 25 kDa were present for up to 2 h, 
which was not seen for BSA. Moreover, in the lower molecular weight region where 
BSA-α-Gal gave rise to weak smeared peptide bands, BSA generated well-defined 
peptide bands. Immunoblot analysis of α-Gal containing proteins upon gastric digestion 
resulted in a rich spectrum of peptides abundant in α-Gal epitopes, where α-Gal epitope 
was detected on the large peptides even after 2 h of in vitro pepsin digestion. Although 
faintly stained, the major peptides carrying the α-Gal epitope, detected at molecular 
weights between 25 and 55 kDa provide a prolonged survival of proteins during gastric 
digestion and a prolonged availability for uptake by intestinal cells.” (Krstic 
Ristivojevic M., Grundström J. et al. 2020) This is of great importance since it was 
shown that α-Gal containing peptides resulting from pepsinolysis are allergenic 
(Apostolovic, Krstic et al. 2017).  




5. Influence of the α-Gal glycosylation on the protein surface on its 
transcytosis through the Caco-2 monolayer, bioavailability 
assessment  
5.1. Introduction 
“There is an evident lack of literature dealing with the fate of the α-Gal carrying 
proteins in the gastrointestinal tract, including processing, uptake, and transport of α-
Gal carrying proteins by the intestinal epithelium”. (Krstic Ristivojevic M., Grundström 
J. et al. 2020) For consequential examination of bioaccessibility of food proteins and 
allergens and their peptides except in vitro simulated gastrointestinal digestion, there are 
established cell-based in vitro models for monitoring protein transport through the 
intestine. “Enterocytes of the intestinal epithelium are the most important cells for 
absorbing nutrients from food and at the same time excluding antigenic macromolecules 
and microbes from crossing the barrier. The human colon carcinoma cell-line Caco-2 is 
used as a model system of the intestinal epithelium. When cultured on permeable 
supports, the cells differentiate into a monolayer that is similar to the small intestinal 
villus epithelium and this monolayer expresses brush border proteins, tight junctions 
between cells, and is highly polarized (Hubatsch, Ragnarsson et al. 2007, Sun, Chow et 
al. 2008). The Caco-2 cell monolayer has been used for investigation of transport of 
food allergens (Moreno, Rubio et al. 2006, Thierry, Bernasconi et al. 2009, Tordesillas, 
Gomez-Casado et al. 2013, Price, Ackland et al. 2014). Also, the Caco-2 in vitro model 
system has been applied to show that allergens can be resistant to digestion and 
maintain their allergenicity after passing the epithelial barrier (Tordesillas, Gomez-
Casado et al. 2013).” (Krstic Ristivojevic M., Grundström J. et al. 2020) Importantly, 
intestinal cells form one of the most important lines of defense which are exposed to 
microbes daily. Hence, in recent years more and more studies revealed that enterocytes 
are in constant communication with the surrounding cells such as cells of the immune 
system which are underlying the intestinal barrier. “Pathogen-derived glycoconjugates 
can be sensed by mammalian lectins, which are of importance in both innate and 
acquired immune responses. Galectin-3, the chimera type galectin, can bind to α-Gal 
(Peterson, Jin et al. 2005, Jin, Greenwald et al. 2006) and is abundantly expressed by 
intestinal epithelial cells (Dumic, Dabelic et al. 2006). Furthermore, galectin-3 is 




upregulated in myeloid and epithelial cells upon microbial stimulation and has mainly 
pro-inflammatory properties (Diaz-Alvarez and Ortega 2017)”.(Krstic Ristivojevic M., 
Grundström J. et al. 2020) 
The main goal of this part of the thesis was to investigate the impact of the α-Gal 
epitope on the protein surface and for the transport rate through the monolayer of 
enterocytes using the Caco-2 monolayer model system. BSA and HSA without and with 
bound α-Gal epitope (BSA-α-Gal and HSA-α-Gal, respectively) were used as the model 
protein for this study.  
5.2. Methodology  
5.2.1.   Reagents  
Proteins were commercially available. BSA and HSA were obtained from Sigma-
Aldrich (Merck, Steinheim, Germany). α-Gal glycosylated BSA (BSA-α-Gal), HSA 
(HSA-α-Gal), and N-Acetyllactosamine conjugated BSA (BSA-NAl) were obtained 
from Dextra Laboratories (Reading, UK). Other chemicals used in experiments were 
p.a. grade and obtained from Sigma-Aldrich unless is stated otherwise. 
5.2.2.   Protein sample preparation 
Used proteins were fluorescently labeled by conjugating AlexaFluor488 (AF488) 
fluorescent dye using an AF488 protein labeling kit (Invitrogen, Molecular Probes, Inc., 
Eugene, Oregon, USA) according to the manufacturer’s instructions. For determination 
of protein concentration commercial kit Pierce Bicinchoninic acid (BCA) Protein Assay 
Kit (Pierce Biotechnology, Rockford, Illinois, USA) was used. 
5.2.3. Cell culture and viability assay 
Caco-2 (HTB37) cell line was obtained from The American Type Culture Collection 
(ATCC, Manassas, Virginia, USA). Caco-2 cells were cultured in complete Minimum 
Essential medium (cMEM) supplemented with 10% of fetal bovine serum (FBS), 2 mM 
glutamine, 1% of nonessential amino acids (NEAA), 100 IU/mL penicillin, 0.1 mg/mL 
streptomycin, and 50 µg/mL gentamicin. Cells were incubated at 37 °C in a humidified 
atmosphere with 5% CO2. Caco-2 cells viability in serum-free media was evaluated by 




MTT assay 1, 4, and 24 h after the media exchange, according to a slightly modified 
procedure of Mosmann (1983). Briefly, Caco-2 cells were seeded in 96-well plates at a 
density of 10 000 cells per well and cultured for the next 21 days to allow the forming 
of the cell monolayer. On the 21
st
 day of culturing, cells were thoroughly washed with 
PBS and incubated with MEM medium supplemented with 2 mM glutamine, 1% of 
NEAA, 100 IU/mL penicillin, 0.1 mg/mL streptomycin, and 50 µg/mL gentamicin but 
without FBS for the next 1, 4 and 24 h. MEM with 10% FBS and mentioned 
supplements were added to the cells in the control wells. The cell culture medium was 
added to blank wells. After the indicated period, 20 µL of MTT solution (5 mg/mL in 
phosphate-buffered saline, PBS) were added to each well and incubated for the next 4 h 
at 37°C. The medium was carefully removed and 200 μL of dimethyl sulfoxide 
(DMSO) was added to dissolve the formed formazan complexes; absorbance was read 
at 492 nm. Data are expressed as the percentage of viability with untreated cells taken as 
100%. 
5.2.4.  Transport through the Caco-2 monolayer 





 (Behrens and Kissel 2003) on cell culture inserts for 12-well plates (ThinCert, 
Greiner Bio-One GmbH, Frickenhausen, Germany) and cultured for 21 days before the 
start of the experiments. The medium was replaced three times per week. Before the 
transport studies and at the end of the experiment, transepithelial electrical resistance 
(TEER) was measured using a Millicell-ERS VoltOhmmeter (Millipore, Amsterdam, 
Netherlands). Only cell monolayers with TEER > 300 Ωcm
2
 were used and none of the 
added proteins had any effect on the TEER. Transport studies were started by adding 
400 µg of AF488-labeled proteins in 500 µL (0.8 mg/mL) complete MEM (cMEM) to 
the apical compartment. Aliquots were withdrawn from the basolateral compartment 
after 1, 2, and 4 h of incubation, and the fluorescence was measured using a FluoroMax-
4 spectrofluorometer (Horiba Scientific, Kyoto, Japan). Protein concentration was 
calculated from standard curves of the corresponding protein, with the limit of detection 
(LOD) of 0.011 µg/mL (LOD = 3Sa/b, where Sa is the standard deviation of the 
response and b is the slope of the calibration curve).”(Krstic Ristivojevic M., 
Grundström J. et al. 2020) 




5.2.5.  Intracellular visualization of proteins and isolation of the endosomal 
fraction of the Caco-2 cell monolayer 
“To visualize the internalization of AF488-labeled proteins, confocal laser scanning 
microscopy (CLSM) was employed (Vukojevic, Heidkamp et al. 2008). Isolation of the 
endosomal fraction of Caco-2 cell lysates was performed as previously described (Mao, 
Ou et al. 2016) with slight modification. Briefly, Caco-2 cells were cultured in the same 
conditions as for transport studies in 6-well plates. Before the addition of treatments, the 
monolayers were washed 3 times with PBS, and the cultivating medium was replaced 
with a medium without FBS. Caco-2 cell monolayers were incubated with 100 µg of 
AF488-labeled BSA or BSA-α-Gal for 4 and 24 h, unstimulated cells were used as 
control. After incubation, the cells were washed 3 times with PBS and detached from 
the culture inserts using an ice-cold PBS-EDTA solution. The cell pellets were washed 
3 times with PBS and lysed with lysis buffer (250 mM sucrose, 50 mM Tris-Cl (pH 
7.4), 5 mM MgCl2, 1 mM EDTA, 1 mM egtazic acid (EGTA)) with a protease inhibitor 
cocktail (Sigma-Aldrich). The suspended cell lysates were left overnight at −80 ° . The 
next day, endosomes were harvested in the third pellet after three centrifugation steps of 
the supernatant: 1st (1000× g, 10 min, performed twice and the supernatants were 
pooled), 2nd (16 000× g, 20 min), and 3rd (100 000× g, 1 h) for immunoblot analysis. 
All centrifugation steps were performed at 4 °C, and for the last ultracentrifugation step 
a Sorvall WX80 ultracentrifuge (Thermo Electron LED GmbH, Langenselbold, 
Germany) with T-880 rotor was used.”(Krstic Ristivojevic M., Grundström J. et al. 
2020) 
5.2.6.  Statistical analysis 
Data are presented as mean ± standard deviation (SD) and were analyzed using 
GraphPad Prism software version 6.04 software for Windows (La Jolla, California, 
www.graphpad.com). Each sample was analyzed in duplicate with two biological 
replicates. The differences were analyzed by two-way ANOVA. The transport rates 
were calculated by linear regression. Differences were considered significant if p < 
0.05. 




5.3. Results  
5.3.1. Parameters which indicate the quality of the Caco-2 monolayer 
Till today FBS supplementation is practically inevitable in culture media used for 
maintenance of almost all cell culture lines. FBS with its very complex composition 
provides optimal conditions for cell culture growth, BSA is one of the most represented 
components of FBS. Because BSA present in the cell culture media can interfere with 
the transport of BSA-α-Gal through the Caco-2 monolayer, it was necessary to reduce 
its presence in media, but this step can cause the disturbance of optimal Caco-2 cell 
viability. Hence, the testing of the viability of cells used in in vitro Caco-2 cell-based 
model in conditions of the reduced quantity of FBS in culture media was the first 
experiment in this part of the thesis. The results of this experiment are presented in 
Figure 19. 
 
Figure 19. The vitality of Caco-2 cells was determined after 21 days of 
differentiation and subsequently, Caco-2 cells were maintained for 1, 4, and 24 h in the 
medium without FBS. CTRL-Cells in the control wells were maintained in the medium 
with FBS. 
From Figure 19 it can be concluded that the maintenance of Caco-2 monolayer in 
the medium without FBS does not influence the vitality of the established Caco-2 
monolayer. This was preferably for the study of the transport of model proteins since 
any disruption of the monolayer could lead to leakage of the test protein to the 
basolateral compartment of the transwell insert.   




Another important parameter that indicates the quality of established cell monolayer 
is the value of TEER. It was adopted that the value of TEER bigger than 300 Ω/cm2 
indicates that the Caco-2 monolayer is of satisfactory quality. Also, TEER must be 
measured during the period of differentiation cell, before and after transport 
experiments.  
 
Figure 20. TEER values of Caco-2 monolayer obtained on the 21
st
 day of cell 
culturing before transport experiment (21DayBE) and after transport experiment 
(21DayAE), CTRL – untreated Caco-2 monolayer. 
Figure 20 presents the TEER values of Caco-2 monolayer obtained before and after 
transport experiments. The variations in obtained values between 300 and 500 Ω/cm
2
 
among used monolayers were expected due to the dynamics and complexity of the used 
system.  Interestingly in some transwell inserts the measured TEER values were higher 
after the transport experiment, while in others were lower than values obtained before 
the experiment. In all cases obtained values of TEER after transport experiments were 
higher than 300 Ω/cm2 which indicates that transport of proteins did not disturb the 
established Caco-2 cell monolayer. 




5.3.2. Effect of glycosylation of proteins on their transport through the Caco-2 
monolayer 
In recent years it becomes evident that protein and allergen transport through 
intestinal epithelia is also an important parameter in sensitization and food allergy 
induction. For this purpose as one of the aims of this thesis, in vitro model system based 
on Caco-2 cells was established which was used for the monitoring and comparison of 
the transport of different proteins (BSA and HSA) which bearing α-Gal epitope (BSA-
α-Gal and HSA-α-Gal) through the monolayer of these cells during 4 h of the 
observation (Figure 21). Their transport rates were compared with the transport rates of 
appropriate controls (BSA and HSA), and with the BSA-NAl which carbohydrates' 
residues are similar to α-Gal (Table 2).  
Table 2. The average transport rates (ng/h) of the different proteins through the 









BSA 142.8 103.9 – 181.7 0.87 ˂ 0.001 
BSA-α-Gal 77.2 53.1 – 101.3 0.84 ˂ 0.001 
HSA 158 117.2 – 198.7 0.88 ˂ 0.001 
HSA-α-Gal 78.8 61.0 – 96.6 0.91 ˂ 0.001 
BSA-NAl 135.0 83.4 – 186.6 0.77 ˂ 0.001 
    † Goodness of fit, ‡ if the slope is different from zero 





Figure 21. Transport (ng) of proteins carrying α-Gal through the intestinal Caco-2 
monolayer. (A) Time-dependent transcytosis of BSA-α-Gal and BSA, n = 4, and (B) 
human serum albumin (HSA) carrying α-Gal (HSA-α-Gal) and HSA, n = 4. * p < 0.05, 
** p < 0.01 and *** p < 0.001 analyzed by two-way ANOVA with Bonferroni’s post 
hoc test; (C) fluorescent detection of BSA-α-Gal and BSA in Caco-2 lysates resolved on 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS PAGE) gel; (D) 
immunoblot detection of the α-Gal epitope in lysates from Caco-2. MW = Molecular 
weight markers and CTRL = untreated Caco-2 cells. 
Fluorescently labeled BSA-α-Gal in the amount of 400 µg was applied on the 
apical side of Caco-2 monolayer and after 1 h of incubation 70 ± 19 ng was transported 
to the basolateral compartment and after 4 h, the amount of transported protein had 
increased to 299 ± 75 ng (Figure 21A). In comparison to glycosylated protein 
unconjugated BSA was transported approximately two times more, administrated in the 
same amount in the apical compartment of Caco-2 monolayer, 136 ± 39 ng had been 
transported after 1 h and 565 ± 113 ng after 4 h of incubation (Figure 21A). Also, the 
transport of HSA-α-Gal through Caco-2 cell monolayer was monitored and compared 
with the transport of unconjugated HSA (Figure 21B). When 400 µg of HSA-α-Gal was 
applied in the apical compartment 72 ± 3 ng was transported in the basolateral 
compartment after 1h of incubation and 306 ± 57 ng of protein was transported in the 




basolateral compartment after 4 h of incubation. The transport of HSA-α-Gal was 
similar to that of BSA-α-Gal but significantly lower compared to the transport of HSA. 
After 1 h of incubation 132 ± 13 ng of HSA had been transported in the basolateral 
compartment when 400 µg of HSA was applied in the apical compartment and 603 ± 
141 ng of HSA was transported in the basolateral compartment after 4 h of incubation. 
The obtained results showed that the amount of transported proteins was constant over 
time which enables the calculation of the average transport rates for investigated 
proteins (Table 2). Unconjugated HSA and BSA have the transport rate almost two 
times higher (158 and 142.8 ng/h) than HSA-α-Gal and BSA-α-Gal (78.8 and 77.2 
ng/h).    
The important question was whether transport through the Caco-2 monolayer 
depends on the type of glycosylation present on the protein. To answer that question we 
compared the transcytosis of BSA-NAl at different time points (Figure 22). When 400 
µg of BSA-NAl was applied in the apical compartment of the transwell inserts, 105 ± 
11 ng of protein was transported in the basolateral compartment after 1 h of incubation 
and 499 ± 167 ng of protein after 4 h of incubation.  
 
Figure 22. Comparison of transcytosis (expressed as an amount of transported protein) 
of BSA-α-Gal, BSA, acetyllactosamine (NAl) conjugated to BSA (BSA-NAl) through 
the Caco-2 monolayer, n = 4, * p < 0.05, ** p < 0.01 and *** p < 0.001 analyzed by 
two-way ANOVA with Bonferroni’s post hoc test. 
According to the result from Table 2, it can be seen that the calculated average 
transport rate of BSA-NAl (135.0 ng/h) is almost the same as the transport of BSA 
(142.8 ng/h). This result indicates that glycosylation alone is not the cause of why BSA-
α-Gal and HSA-α-Gal have two times smaller transport rates than BSA and HSA, but 
also the type of glycosylation. 




To confirm the presence of the intact BSA proteins with and without α-Gal 
epitope in the Caco-2 cells, after transport experiments Caco-2 cell monolayers were 
collected, cells were lysed and cell lysates were resolved on SDS PAGE. The used PAA 
gels were illuminated and fluorescently labeled BSA and BSA-α-Gal were visible 
(Figure 21C). The difference in the MW of the resolved fluorescently labeled proteins 
suggests that BSA-α-Gal was intact in the Caco-2 cell lysates. For the additional 
confirmation of the detection of the α-Gal epitope western blot analysis with a chicken 
single-chain variable fragment (ScFV) anti-α-Gal was performed (Figure 21D). In 
Figure 21D is a visible band which corresponds to the MW of approx. 75 kDa and it is a 
strong confirmation that the α-Gal epitope is still present on the intact protein.  
According to the results of this experiment, it can be concluded that the in vitro 
developed model system based on Caco-2 cells monolayer can be used for the 
investigation of the transport rate of different glycosylated food allergens, as well as 
how specific glycosylation can affect this process. 
5.3.3. The α-Gal carrying proteins can be detected in endosomes  
In the previous experiment, the presence of intact BSA and BSA-α-Gal was 
confirmed inside of the Caco-2 cell. In the next experiment, the confocal laser scanning 
microscopy (CLSM) was applied for visual confirmation of the presence of the 
fluorescently labeled BSA and BSA-α-Gal inside of Caco-2 cells. This analysis also 
enables us to get an impression of the spatial distribution of these proteins inside of 
cells. 
 
Figure 23. Spatial distribution of fluorescently labeled BSA-α-Gal and BSA with green 
fluorescent dye AF488 in Caco-2 cells after 4 h of incubation at 37 ˚C analyzed by 
confocal laser scanning microscopy. CTRL- untreated cells with fluorescently labeled 
protein. 




After 4 h of incubation, CLSM analysis reveals the presence of green fluorescent 
dye only in the Caco-2 cells which were incubated with   BSA-α-Gal. The lack of the 
green signal in the control cells as well as in the cells incubated with BSA suggests that 
there was no accumulation of the BSA inside cells. Scattered green in the cytosol of 
Caco-2 cell, incubated with BSA-α-Gal implicate that protein is still was present in 
some small subcellular structures such as endosomes after 4 h of incubation. 
Further, for the confirmation of the spatial distribution of proteins inside the 
cells, differential centrifugation was used to isolate endosomes from Caco-2 cells. 
Again, using fluorescence detection the presence of intact proteins was confirmed in the 
cell lysates and subsequently in the endosomal fraction of cell lysates after 4 and 24 h of 
incubation of Caco-2 cells with BSA and BSA-α-Gal (Figure 24A and 24B). The 
resolved protein content of the endosomal fraction of Caco-2 cell lysates via SDS 
PAGE was transferred on the PVDF membrane and probed with a polyclonal anti-BSA 
antibody (Figure 25). In the corresponding endosomal fraction of Caco-2 cell lysates, 
both BSA and BSA-α-Gal were detected after 4 and 24 h of incubation. Interestingly 
BSA was found in both unstimulated Caco-2 cells (CTRL) and BSA-α-Gal stimulated 
cells, probably due to its presence in FBS supplement in the culturing medium used 
before the transport experiment. 
 
Figure 24. Fluorescent detection of BSA and BSA-α-Gal in (A) Caco-2 lysates resolved 
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS PAGE) gel and (B) 
endosomal fraction of cell lysates after 4 and 24 h of incubation of Caco-2 cells with 
BSA and BSA-α-Gal. CTRL-untreated Caco-2cells, MW-Molecular weight markers. 





Figure 25. Immunoblot analysis of an endosomal fraction of cell lysates after 4 and 24 
h of incubation of Caco-2 cells with BSA and BSA-α-Gal using a polyclonal anti-BSA 
antibody. CTRL=unstimulated Caco-2cells, MW = molecular weight markers. 
 The detection of the α-Gal epitope in the endosomal fraction of Caco-2 cell 
lysates was performed using a monoclonal anti-α-Gal M86 antibody (Figure 26). After 4 
h of incubation of Caco-2 cells with BSA-α-Gal, the α-Gal epitope was detected at the 
MW of approx. 75 kDa which corresponds to the intact protein. Moreover, except intact 
BSA-α-Gal, an additional band containing the α-Gal epitope was detected at the approx. 
MW of 150 kDa in the endosomal fraction of the Caco-2 cell lysates. This additional 
band is probably a dimer of the BSA molecule. 
 
Figure 26. Immunoblot detection of BSA and BSA-α-Gal using monoclonal anti-α-Gal 
M86 antibody in the endosomal fraction obtained by differential centrifugation of Caco-
2 cell lysates after 4 h of incubation, 2°Ab = control of unspecific binding of the 
secondary antibody, MW = Molecular weight markers, and CTRL = unstimulated Caco-
2 cells. 




5.3.4. The α-Gal carrying proteins do not influence the level of galectin-3 in 
Caco-2 cells 
Recently the role of galectin-3 is featured in both innate and acquired immune 
responses. In that sense, it was of importance to examine if there are potential changes 
in the levels of the galectin-3 in differentiated Caco-2 cells upon incubation with α-Gal 
conjugated and unconjugated BSA at different time points (Figure 27). According to the 
results present in this figure, it can be seen that the intensities of galectin-3 bands in 
stimulated Caco-2 cells are the same as the band in the unstimulated cells, which 
indicates that the galectin-3 level in Caco-2 cells did not change during transport and 
uptake of BSA-α-Gal by Caco-2 monolayers. 
 
Figure 27. Western blot detection of galectin-3 using the polyclonal anti-human 
galectin-3 antibody in Caco-2 cell lysates after 4 and 24 h of incubation Caco-2 cells 
with BSA and BSA-α-Gal. MW = Molecular weight markers, and CTRL = unstimulated 
Caco-2 cells. 
5.4. Discussion  
Investigation of complex processes of food digestion, nutrients bioaccessibility, and 
bioavailability is quite challenging for researchers from the different aspects of research. 
To solve this puzzle it is necessary to start whit simpler models and aspects and 
accumulate knowledge to obtain a broader and precise picture of ongoing processes. 
Since food allergens are transported through gut epithelial cells, it is of importance to 
investigate the transcytosis of novel allergenic foods.  




The results obtained for cell vitality confirmed that culturing conditions did not 
interfere with Caco-2 cell viability and monolayer integrity. Consequently obtained 
values of TEER measurements before and after transport experiments confirmed that 
the Caco-2 monolayer was intact and maintained its integrity after transcytosis. 
Regarding the transport “it was demonstrated that the presence of the α-Gal epitope on 
BSA hampers transport through the intestinal Caco-2 monolayer compared to 
unconjugated BSA, which could be a possible reason why the allergic reaction to α-Gal 
is delayed. Interestingly, the transport of BSA-NAl was higher than that of BSA-α-Gal, 
even though the carbohydrates α-Gal and NAl are of similar size, suggesting that the 
slower transport of BSA-α-Gal is glycosylation specific. In contrast to our results, 
Román-Carrasco, Lieder et al. (2019) showed that only α-Gal bound to lipids, not to 
proteins, could be detected in the basolateral medium after transport through the Caco-2 
monolayer. However, in both studies different methods for the detection of transported 
proteins and peptides as well as the amount of α-Gal containing proteins added was 
different. In this study Krstic Ristivojevic M., Grundström J. et al. (2020) 800 µg/mL of 
pure α-Gal containing protein was applied compared to 1 mg/mL of digested red meat 
extract in the study of Román-Carrasco, Lieder et al. (2019), suggesting that the lower 
amount of α-Gal containing proteins in the extract could not be detected”.(Krstic 
Ristivojevic M., Grundström J. et al. 2020)  
Intact proteins with and without α-Gal epitope were detected in Caco-2 cell lysates 
upon transport studies. Moreover, CLSM revealed that BSA-α-Gal was scattered inside 
the living cells and its apparent accumulation was notable. On the other hand lack of the 
green signal arising from BSA suggests that intact protein could not be detected inside 
of the Caco-2 cells although its presence in Caco-2 cell lysates was confirmed. One 
explanation for the obtained results is that the CLSM fluorescent signal is collected 
from max 40 to 50 cells in one confocal plane while for the lysate preparation a 
minimum of 20 000 cells was used. Also in immunoblots, the signal is amplified by 
using a primary and secondary antibody. “It has been previously shown that 
mannosylated BSA is transported by endosomes and lysosomes in alveolar 
macrophages (Wileman, Boshans et al. 1985). In this study, BSA-α-Gal and the α-Gal 
epitope on the intact protein were detected in the endosomal fraction of Caco-2 cell 
lysates, and intact protein was detected even after 24 h of incubation. One of the 




possible explanations of this delayed processing is that the presence of α-Gal epitopes 
on the protein surface leads to steric interference that impedes access to cellular and 
endosomal proteases involved in protein degradation (Krstic Ristivojevic M., 
Grundström J. et al. 2020). It has been already demonstrated that protein modifications, 
such as lactosylation, can influence protein hydrolysis catalyzed by cathepsin D, a 
protease present in endolysosomal cell compartments (Kastrup Dalsgaard, Holm 
Nielsen et al. 2007). In the used model of the intestinal epithelium, any effect on the 
expression of galectin-3 in the Caco-2 cells after stimulation with BSA-α-Gal is not 
seen. BSA-α-Gal is a harmless protein and since healthy gut epithelium should be 
tolerant to commensal bacteria of the gut flora, which expresses α-Gal, an inflammatory 
response cannot be expected.” (Krstic Ristivojevic M., Grundström J. et al. 2020) In the 
shaping of the biological process of immune tolerance to food and microbial antigens 
besides immune cells also all the cells in the human intestine are participated (Miron 
and Cristea 2012).  
“The main results of this study are that α-Gal carrying proteins are transported 
through the intestinal Caco-2 monolayer in significantly lower amounts compared to 
non-α-Gal carrying proteins and that BSA-α-Gal is notably accumulated and retained in 
endosomes of the intestinal cells. The results, contribute significantly to the 
understanding of the mechanisms underlying the delayed onset of mammalian meat 
allergic symptoms. However, further research is needed to elucidate the kinetics of the 












6. Influence of the α-Gal glycosylation on the protein surface with 
respect to uptake and degradation in immature monocyte-derived 
dendritic cells   
6.1. Introduction 
The cascade of processes leading to an allergic reaction to food starts with the 
digestion process and bioaccessibility of allergens through their transport across the 
intestinal barrier and encounter with immune cells. One unusual characteristic of red 
meat allergy is delayed symptoms, which usually appear from 3 to 6 hours after meat 
consumption (Nunez, Carballada et al. 2011). It is assumed that the main reason for this 
is the delayed appearance of the allergen in the bloodstream as well as disturbances in 
its processing by the immune cells such as dendritic cells and T-cells. “The DCs are 
professional antigen-presenting cells and the role of immature DCs is sampling the 
environment to capture antigens and initiate an adaptive immune response by activating 
and priming naive CD4+ T-cells (Banchereau, Briere et al. 2000). The subsequent 
outcome of this interaction can be tolerance promotion or induction of active immunity 
(Steinman 2003). Internalization and degradation of antigens by DCs are important 
steps in determining whether an antigen will be treated as dangerous or innocuous 
(Lambrecht and Hammad 2010). Antigens can be actively internalized in several 
different ways: receptor-mediated endocytosis, macropinocytosis, and phagocytosis 
(Roche and Furuta 2015). After uptake, the vesicle formed fuses with endosomal 
compartments where the antigens will be processed into peptides that can be further 
presented on the cell surface.”(Krstic Ristivojevic, Grundstrom et al. 2018)  It is very 
interesting how glycans on glycoprotein were processed by DCs and how the position of 
the glycan group within MHC on the DCs influences the recognition of the T-cell and 
antigen-presenting cells. There are two possible scenarios, in the first scenario, glycan is 
linked to an amino acid serves to anchors the glycopeptide into the MHC and does not 
participate in MHC binding and as such is nonimmunogenic. In the second scenario 
when glycan is linked to an amino acid that is pointing away from the MHC molecule 
and thus participates in MHC in the binding between MHC and T cell, moreover it 
makes dominant part of recognition by T cell. In that case, the glycopeptide is 
designated as immunogenic (Werdelin, Meldal et al. 2002). Thus it is very important to 




investigate the uptake and the routes of internalization of α-Gal containing proteins by 
the DCs. Because of this, the last aim of this thesis was to investigate how α-Gal glyco-
component on the protein surface influence their uptake and processing by iMDDCs. 
6.2. Methodology 
6.2.1. Reagents 
Used proteins are commercially available. BSA, HSA, bTG, monodansylcadaverine 
(MDC), and cytochalasin D (CytD) were obtained from Sigma-Aldrich (Saint Louis, 
MO, USA). α-Gal glycosylated BSA (BSA-α-Gal), HSA (HSA-α-Gal), and N-
Acetyllactosamine conjugated BSA (BSA-NAl) were obtained from Dextra 
Laboratories (Reading, UK). Other chemicals used in experiments were p.a. grade and 
obtained from Sigma-Aldrich unless is other stated. 
6.2.2. Fluorescent labeling of proteins 
Used proteins (BSA, BSA-α-Gal, BSA-NAl, HSA, HSA-α-Gal, and bTG) were 
fluorescently labeled by conjugating of AlexaFluor488 (AF488) fluorescent dye using 
an AF488 protein labeling kit (Invitrogen, Molecular Probes, Inc., Eugene, Oregon, 
USA) according to the manufacturer’s instructions. For determination of protein 
concentration commercial kit Pierce Bicinchoninic acid (BCA) Protein Assay Kit 
(Pierce Biotechnology, Rockford, Illinois, USA) was used. 
6.2.3. Donors 
In this study, buffy coats from 18 healthy blood donors and four patients diagnosed 
with red meat allergy were used. Diagnose of red meat allergy was made by a physician 
experienced in allergic diseases. 
6.2.4. Ethics Statement 
In this study, all experiments were following relevant guidelines and regulations and 
approved by the local ethics committee (2014/847-32 and 2016/1447-32). The study 
participants gave written informed consent for the sample collection. 




6.2.5. Cell isolation and culturing 
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats by 
density gradient centrifugation using Ficoll–Paque (GE Healthcare, Uppsala, Sweden). 
CD14 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) were used for 
CD14+ monocytes isolation following the manufacturer’s instructions. The isolated 
CD14+ monocytes were then cultured for 6 days. The medium for cultivation was 
‘complete’ R MI (cR MI) consisting of R MI‐1640 (Gibco) supplemented with 25 
µg/mL gentamicin (Gibco), 10% (v/v) heat‐inactivated fetal calf serum (FCS; Hyclone, 
Logan, UT), 2 mM L‐glutamine, 100 IU/mL penicillin (Gibco), 100 µg/mL 
streptomycin (Gibco) and 50 µM β‐mercaptoethanol (KEBO‐lab, Spånga, Sweden) in 
the additional presence of 800 U recombinant interleukin‐4 (rIL‐4  Nordic BioSite, 
Täby, Sweden) and 10 ng/mL granulocyte-macrophage colony‐stimulating factor (GM‐
CSF; Biosource International, Camarillo,  A). Fresh rIL‐4 (800 U/mL) and GM‐ SF 
(10 ng/mL) were added after 3 days of culture. After 6 days when the MDDCs exhibited 
a typical immature phenotype and uptake analysis were performed. “For uptake 
analysis, immature MDDCs (iMDDCs) were seeded in multiwell flat-bottom tissue 
culture plates and incubated at 37 ˚  with 10 µg/10
6
 cells of fluorescently labeled 
proteins for 1, 2, and 4 h. Internalization was inhibited by incubating the iMDDCs at 
4°C, or by adding MDC (200µM) or CytD (2µM) 30 min before adding the proteins for 
each time point. In all experiments, untreated iMDDCs were used as a negative 
control.” (Krstic Ristivojevic, Grundstrom et al. 2018) 
6.2.6. Flow cytometry 
“Cells were harvested after incubation with AF 488 labeled proteins and stained 
with LIVE/DEAD Aqua stain (Molecular probes, Thermo Fisher) or fixable viability 
stain 780 (BD Bioscience, San Jose, Calif., US). After this, the samples were fixed with 
2% PFA and surface markers (CD11c-PE-Cy7 (clone B-ly6), CD14-APC (clone 
M5E2), both from BD Bioscience) were stained. At least 10 000 single cell events were 
collected on a FACSCanto II flow cytometer using the BD FACS Diva software (BD 
Bioscience). Data analysis was performed using FlowJo version 10 software (FlowJo 
LLC, Oregon, US)” (Krstic Ristivojevic, Grundstrom et al. 2018) and used gating 
strategy is shown in Figure 28. 





Figure 28. Gating strategy for assessment of protein uptake by immature monocyte-
derived dendritic cells after 4h of incubation iMDDCs with BSA and BSA-α-Gal. 
CTRL= untreated cells. Data analysis was performed using FlowJo version 10 software. 
6.2.7. SDS-PAGE and Immunoblot analysis of α-Gal proteins 
“After incubation with AF 488 labeled BSA and BSA-α-Gal for 1, 2, 4, 6, 8 and 16 
h, iMDDCs were pelleted and the cell pellets were treated with 
radioimmunoprecipitation lysis buffer. The lysates were clarified by centrifugation and 
the soluble fractions were separated by SDS-PAGE under reducing conditions. 
Intracellular AF 488 labeled proteins were visualized on a ChemiDoc system (Bio-Rad, 
Hercules, CA, US). Following visualization, resolved proteins were transferred to 
PVDF (0.2 µm pore size) using a Bio-Rad turbo system. The membranes were probed 
with a previously validated 24 monoclonal anti-α-Gal antibody (M86, Enzo Life 
Sciences, Farmingdale, NY, USA) followed by alkaline phosphatase labeled goat anti-
mouse IgM antibody (Southern Biotech, Birmingham, AL, USA). Immunoreactive 
bands were visualized using NBT and BCIP substrates (Bio-Rad).” (Krstic Ristivojevic, 
Grundstrom et al. 2018) 




6.2.8. Confocal Laser Scanning Microscopy 
“The iMDDCs were cultured for 1 h at 37°C on coverslips coated with poly-L-
lysine (Neuvitro Corporation, WA, USA) to allow cell attachment. After 1 and 4 h of 
incubation with AF 488 labeled proteins (10µg/10
6
 cells), the coverslips were washed 
with PBS and stained with purified anti-human HLA-DR antibody (clone L243, 
BioLegend, San Diego, CA, USA), followed by a secondary goat anti-mouse IgG 
antibody conjugated with Alexa Fluor 555 (AF 555) (clone Poly4053, BioLegend). The 
coverslips were mounted using Prolong Gold Antifade reagent with DAPI (Molecular 
probes). The CLSM was performed using the LSM 510 Meta system (Carl Zeiss, Jena, 
Germany) individually modified to allow imaging with improved detection efficiency 
using avalanche photodiodes 25. The alpha Plan-Fluar 100x/1.45 oil immersion 
objective (Zeiss MicroImaging GmbH, Jena, Germany) was used throughout. Images 
were acquired at 1024×1024 pixel resolution, scanning speed 12.6 µs/pixel, without 
averaging, and prepared for publication using the Zeiss LSM Image Browser software.” 
(Krstic Ristivojevic, Grundstrom et al. 2018) 
6.2.9. Statistical analysis 
Data are presented as mean value ± SD. Differences in protein uptake at the same 
time point were analyzed by two-way ANOVA using Bonferroni post hoc test. 
Differences in protein uptake at different time points were analyzed by two-way 
ANOVA using Tukey post hoc test. The effect of inhibition and uptake for red meat 
allergic patients was analyzed by paired t-test. Differences were considered significant 
if P < 0.05. For statistical analysis, GraphPad Prism version 6.00 software for Windows 
(GraphPad Software, La Jolla, CA, USA) was used. 
6.3. Results 
6.3.1. The α-Gal glycosylation of protein influences protein uptake in iMDDCs 
As one of the cells of the immune system which underlines the layer of the 
intestinal cells and one of the most important cells in the initiating of immune 
responses, DCs were inevitable in the examination of the uptake of the proteins 
conjugated to α-Gal epitope and unconjugated ones. The iMDDCs differentiated from 




healthy individuals were analyzed by flow cytometry after 1, 2, and 4 h of the 
incubation with fluorescently labeled α-Gal and non-α-Gal carrying BSA or HSA 
(Figure 29). 
 
Figure 29. Time-dependent uptake of (A) BSA-α-Gal and BSA, n = 10, and (B) HSA-
α-Gal and HSA, n = 8, by iMDDCs generated from healthy donors. *p < 0.05, and ***p 
< 0.001 analyzed by two-way ANOVA with Bonferroni’s post hoc test. (C) Uptake of 
BSA-α-Gal and BSA by iMDDCs generated from red meat allergic patients after 4 h of 
incubation, n = 4. **p < 0.001 analyzed by paired t-test. 




From the obtained results it is evident that the internalization of BSA-α-Gal by 
iMDDCs was significantly higher compared to internalization of BSA at all three time 
points (p ˂ 0.0001, Figure 29A). Also, the accumulation of BSA-α-Gal, inside cells, has 
been increasing along with the period of incubation (p = 0.0107, from 1 h to 4 h). 
Furthermore, similar results were obtained for the uptake of the HSA-α-Gal and 
unconjugated HSA (Figure 29B). Uptake and internalization of both proteins increased 
over time (HSA-α-Gal: p < 0.0001 from 1 to 4 h and p = 0.0002 from 2 to 4 h, HSA: p = 
0.0441 from 1 to 2 h, p < 0.0001 from 1 to 4 h and 0.0127 from 2 to 4 h). Also, the 
uptake of HSA-α-Gal was significantly higher compared to the uptake of HSA (p < 
0.0001 at all three time points).  
In the next experiment iMDDCs differentiated from four red meat allergic 
individuals were used for the monitoring of the uptake and internalization of the α-Gal 
conjugated and unconjugated BSA after 4 h of incubation with iMDDCs (Figure 29C). 
Obtained results show that BSA-α-Gal was internalized by these cells a statistically 
significant in a higher degree than BSA (p = 0.0013). This was similar to the result 
obtained for healthy individuals. 
6.3.2. Influence of protein size and the type of carbohydrate modification 
carried by the protein on the uptake of protein by  iMDDC  
In the previous experiment, it was proved that iMDDCs very efficiently uptake the 
α-Gal-proteins. In the next experiment, iMDDCs obtained from the healthy individuals 
were used for the investigation of whether the molecular size of proteins or the type of 
carbohydrate modification carried by the protein affect uptake of proteins by iMDDC. 
For this experiment, besides BSA and BSA-α-Gal as the controls, bTG and BSA-NAl 
were used.  These two proteins were chosen because bTG is naturally carrying α-Gal 
epitope and has 10 times bigger molecular weight than BSA-α-Gal, while BSA-NAl has 
a carbohydrate modification N-acetyllactosamine similar size as α-Gal. The uptake of 
above mentioned all proteins labeled by fluorescence dye AF 488 by iMDDCs after 1 
and 4 h of incubation was monitored by flow cytometry. 
The obtained results showed that the uptake of bTG was significantly higher 
compared to BSA after 1 and 4 h of incubation (p < 0.0001). The uptake of bTG was 




comparable to the uptake of BSA-α-Gal (Figure 30A). The uptake and internalization of 
BSA-NAl after 1 and 4 h of incubation of iMDDCs was significantly lower compared to 
BSA-α-Gal (p < 0.0001), and it was comparable to the uptake of BSA (Figure 30B).  
 
Figure 30. The impact of protein size and conjugation on protein uptake. The uptake of 
bTG compared to the uptake of BSA-α-Gal and BSA. (B) The uptake of BSA-NAl 
compared to the uptake of BSA-α-Gal and BSA. iMDDCs were generated from healthy 
blood donors, n = 4. ***p < 0.001 analyzed by two-way ANOVA with Bonferroni’s 
post hoc test. 
According to the obtained results, it can be concluded that: the size of protein did 
not have any effect on the uptake of protein by iMDDC; the type of glycosylation has a 
big influence even when the size of glycans similar. 
6.3.3. Investigation of the internalization routes of proteins by iMDDCs  
The uptake and internalization of different proteins (BSA, HSA, bTG) carrying to 
α-Gal epitope by iMDDCs obtained from healthy blood donors and red meat allergic 
patients were demonstrated in the previous experiments. For the understanding of these 
processes, it is very important to examine a potential route of the entrance of those 
proteins into the cells as well as whether the uptake of proteins into iMDDCs is an 
active process. In this experiment, the uptake of BSA and BSA-α-Gal in the presence of 
two inhibitors CytD and MDC and at 4°C by iMDDCs was investigated. 
According to the obtained results in Figure 31, it can be seen that the uptake of α-
Gal carrying proteins is an active process since internalization of BSA and BSA- α-Gal 
was significantly lower (p = 0.0165; p = 0.0017, respectively) during 4h of cells 
incubation at 4 °C compare to the incubation at 37 °C. 





Figure 31. The internalization of BSA-α-Gal and BSA by iMDDCs obtained from 
healthy blood donors after 4 h of incubation at 37 and 4°C, n = 4 (BSA-α-Gal, p = 
0.0017, and BSA, p = 0.0165), * = p < 0.05, ** = p < 0.01 and *** = p < 0.001 analyzed 
by paired t-test. 
For the analysis of the route of the protein internalization, inhibitory agents such 
as CytD and MDC were added to iMDDCs cultures 30 min before the addition of BSA-
α-Gal or BSA. The effect of CytD which inhibits macropinocytosis and MDC which 
inhibits receptor-mediated endocytosis, on the uptake of BSA-α-Gal or BSA by 
iMDDCs was analyzed by flow cytometry after 1 and 4 h of incubation of iMDDCs 
with BSA-α-Gal or BSA (Figure 32). 
 Incubation of iMDDCs with both CytD and MDC statistically significant 
inhibited the internalization of BSA-α-Gal and BSA after 1 h (Figure 32A and C) and 4 
h of incubation (Figure 32B and D). The effect of both inhibitors on the inhibition of 
uptake of BSA-α-Gal is more prominent after 1h of incubation than 4h of incubation. 
According to the number of cells labeled by the fluorescent dye, MDC shows a bigger 
effect on the inhibition of BSA-α-Gal uptake than CytD after 1h of incubation. 





Figure 32. The internalization of BSA-α-Gal and BSA by iMDDCs obtained from 
healthy blood donors after 1 h (A and C) and 4 (B and D) of incubation of iMDDCs and 
proteins in the presence of (A) and (B) Cytochalasin D,( n = 6; BSA-α-Gal and n = 5; 
BSA), and (C) and (D) Monodansylcadaverine (n = 7). *p < 0.05, ***p < 0.001 
analyzed by paired t-test. 
6.3.4. The processing of proteins with and without α-Gal epitope by iMDDC 
Although all previous experiments indicate that proteins, which carrying the α-Gal 
epitope are internalized by iMDDCs nothing is known about their further fate in these 
cells. One important question is: in which way proteins that carrying α-Gal epitope are 
processed by iMDDCs. Are any differences in the rate of processing of proteins with 
and without the α-Gal epitope? In an attempt to get answers to these questions, in the 
next experiment, the presence of BSA and BSA-α-Gal labeled by fluorescent dye AF 
488, in the lysates of iMDDCs obtained at different time points was analyzed by SDS 
PAGE. The bands of BSA and BSA-α-Gal in the gel were visualized by fluorescent 
detection (Figure 33A), while the presence of α-Gal epitope on the intact proteins or 
their digested fragments was analyzed by immunodetection using monoclonal anti-α-
Gal M86 antibody (Figure 33B).  
The bands of BSA-α-Gal and BSA were detected at MW which corresponds to 
approx. MW of their intact form. Interestingly in the case of BSA-α-Gal, a band above 
75 kDa, which corresponds to the intact protein was present for up to 16 h of uptake of 




BSA-α-Gal. The protein band lower than the intact protein was detected after 4, 6 and 8 
h of BSA-α-Gal incubation (Figure 33A). The detected band at lower MW than intact 
BSA-α-Gal probably represents degraded products of the protein. Regarding the uptake 
of BSA, a strong protein band, which corresponds to the intact protein was detected for 
up to 6 h of uptake while after 8 and 16 h of uptake very weak protein band could be 
noted at a slightly higher MW.  
When the presence of the α-Gal epitope is analyzed in iMDDCs lysates, it can be 
seen from Figure 33B that the α-Gal epitope was present for up to 16 h at MW of the 
band which corresponds to the intact protein. Besides this band, in all time points of the 
protein uptake weak protein bands at approx. MW of 150 kDa was detected.   
 
Figure 33. (A) Fluorescent detection of BSA-α-Gal and BSA labeled by fluorescent dye 
AF 488 and (B) Western blot detection of the α-Gal epitope using monoclonal anti-α-
Gal M86 antibody in iMDDCs lysates prepared from iMDDCs after 1 to 16 h of 
incubation with BSA-α-Gal and BSA, and resolved using SDS polyacrylamide gel 
electrophoresis. iMDDCs were generated from healthy blood donors, 
CTRL=unstimulated cells. 
6.3.5. The α-Gal containing proteins are scattered in the cytoplasm of 
iMDDCs 
For a better understanding of the processes behind the processing of proteins that 
carry α-Gal epitopes such as BSA-α-Gal and bTG inside of DCs, CLSM analysis was 
used. The iMDDCs were incubated with BSA-α-Gal and BSA AF488 labeled for 1 and 
4 h at 37 ˚ , after the end of this period iMDDCs were prepared for CLMS to monitor 




the uptake of proteins because this analysis enables very accurate prediction of the 
spatial distribution and localization of proteins inside the cells (Figure 34). Besides 
these proteins, CLSM was used for the monitoring of the uptake of bTG and BSA-NAl, 
by iMDDCs. The bTG, which naturally possesses α-Gal epitope as posttranslational 
modification and has the MW 10 times higher than the MW of BSA-α-Gal and BSA-
NAl, which carrying a glycan similar size as α-Gal were used to check how iMDDCs 
uptake and process these proteins (Figure 35). 
The obtained images using CLSM are presented in Figure 34 and fluorescent green 
signals arising from BSA-α-Gal were detected in almost 50% of the iMDDCs 
represented in that confocal plane. Furthermore, after 4 h of incubation green 
fluorescent signal was dominantly localized in the perinuclear region of almost all 
iMDDCs represented in that confocal plane. On the other hand, there was no detectable 
green signal arising from fluorescently labeled BSA neither after 1 or 4 h of the 
monitored uptake. Importantly CLSM imaging was following the results obtained using 
flow cytometric analysis. 





Figure 34. The uptake of BSA-α-Gal and BSA by iMDDCs after 1 h and 4 h of 
incubation iMDDC with AF488 labeled proteins at 37 °C was analyzed by confocal 
laser scanning microscopy. CTRL = unstimulated iMDDCs, green = BSA-α-Gal or 
BSA, red = HLA-DR and blue = DAPI stained nuclei. 
It is evident the lack of green fluorescent signals arising from BSA-NAl after 1 
and 4 h of incubation of iMDDCs with protein, while strong green signal arising from 
bTG was detected scattered in cell cytosol of almost all iMDDCs after 1 and 4 h of the 
uptake. Overall results demonstrated that proteins with α-Gal epitope as its sugar 
modification were retained and accumulated inside of iMDDCs. 





Figure 35. The uptake of BSA-NAl and bTG by iMDDCs after 1 h and 4 h of 
incubation iMDDC with AF488 labeled proteins at 37 °C was analyzed by confocal 
laser scanning microscopy. Green = BSA-NAl or bTG, red = HLA-DR and blue = 
DAPI stained nuclei. 
 
6.4. Discussion 
“The α-Gal rich foods elicit delayed allergic symptoms in red meat-allergic patients, 
which could be due to uptake and processing by DCs. The present study (Krstic 
Ristivojevic, Grundstrom et al. 2018), shown efficient uptake of the α-Gal model 
antigens like BSA-α-Gal and HSA-α-Gal by in vitro cultured human iMDDCs. Similar 
results were obtained for iMDDCs generated from healthy individuals and red meat 
allergic patients, indicating that altered uptake of α-Gal in DCs per se is not a factor 
contributing to red meat allergy. However, DCs are likely involved in the sensitization 
phase of red meat allergy where α-Gal containing proteins may be taken up in the close 
vicinity of a tick bite. In atopic individuals, the DCs may then initiate allergic 




sensitization through skewing of CD4+ T cells towards a Th2 response. A recent report 
showed that the context of allergen uptake is important for the maturation of iMDDCs 
and that the maturation effect differed between healthy and atopic donors (Aglas, Gilles 
et al. 2018). 
Interestingly, the uptake of BSA and HSA alone was not as efficient as for their α-
Gal carrying counterparts. Thus, the presence of α-Gal on the surface seems to enhance 
the internalization of the protein, suggesting an α-Gal dependent uptake mechanism. 
The results are in line with previous studies on glycosylated protein uptake, where a 
100-fold higher uptake of mannosylated BSA compared with non-mannosylated BSA 
was demonstrated (Engering, Cella et al. 1997). Furthermore, advanced glycation end 
products of ovalbumin were taken up more efficiently by iMDDCs compared with 
ovalbumin (Hilmenyuk, Bellinghausen et al. 2010). 
It also investigated if the size and type of conjugation of the proteins have an impact 
on the uptake. The iMDDCs from healthy individuals showed no difference in the 
uptake of BSA-α-Gal and bTG even though the MW of bTG is approx. 10 times higher 
than the MW of BSA-α-Gal. Interestingly, the uptake of BSA-NAl was several times 
lower compared to BSA-α-Gal, even though the α-Gal and NAl carbohydrates are of 
similar size. Previous studies have shown that MDDCs internalize BSA with different 
glycosylation patterns to very varying extent (Avraméas, McIlroy et al. 1996), and for 
other glycosylated allergens, the mannose receptor plays a major role in glycoallergen 
recognition and uptake (Royer, Emara et al. 2010). The results of this study strongly 
suggest that the specific glycosylation of protein antigens predominantly influences the 
uptake, while the size of the protein is not a decisive factor. This is in line with previous 
studies which have shown that human DCs, in addition to protein antigens, can 
internalize large size particles (Foged, Brodin et al. 2005) while the key factor that 
influences protein uptake is the surface architecture (Engering, Cella et al. 1997). 
What was next elucidated in this study, whether α-Gal could be detected in the 
cytoplasm of iMDDCs. Fluorescence detection confirmed the presence of BSA-α-Gal in 
iMDDC cytoplasm. Moreover, SDS PAGE analysis showed that BSA-α-Gal was 
detected after up to 16 h of incubation, while BSA was only detected up to 6 h. Western 
blot with monoclonal anti-α-Gal antibody confirmed that the BSA-α-Gal still carries the 




epitope. These results suggest that the degradation pathway of α-Gal carrying proteins is 
slower than for non-carrying proteins and that they are stored intact inside of cells. Most 
likely the α-Gal glycosylation protects the protein from degradation and as such may 
increase the processing time and exposure on the surface of the cell. Other studies have 
indeed shown that reduced degradation increases antigen presentation on MHCII 
(Delamarre, Pack et al. 2005) and that the allergenic Bet v 1a was degraded slower than 
its hypoallergenic isoform Bet v 1d (Freier, Dall et al. 2015), suggesting that processing 
time affects allergenicity. This is also in line with the delayed appearance of symptoms 
in red meat allergic patients. 
The route of internalization of proteins was analyzed by adding CytD and MDC to 
the iMDDC cultures which resulted in partial inhibition of the internalization of BSA, 
regardless of the presence of α-Gal. The inhibition was stronger after 1 h of incubation 
than after 4 h, which probably reflects a temporary effect by both inhibitory agents. 
MDC blocks receptor-mediated endocytosis whereas CytD affects the invagination of 
the cell membrane by blocking actin polymerization, which inhibits macropinocytosis 
and phagocytosis (Ivanov 2008). However, the blocking of actin polymerization may 
also inhibit receptor-mediated endocytosis (Ivanov 2008). Fluorescently labeled BSA 
can be used for measuring uptake via macropinocytosis, but as with chemical inhibition 
of antigen-uptake, it is difficult to unambiguously distinguish between 
macropinocytosis and receptor-mediated endocytosis as the uptake mechanism in DCs 
(Liu and Roche 2015). These results thus indicate that both receptor-mediated 
endocytosis and macropinocytosis are involved in the uptake of α-Gal containing 
proteins. 
The confocal analysis revealed accumulated BSA-α-Gal and bTG after 1 and 4 h of 
incubation, whereas no internalization of BSA and BSA-NAl could be detected at any 
time point. Thus, for antigen uptake, the conjugated sugar seems to be more important 
than the protein size, in line with the flow cytometric analysis. After 1 h the proteins 
were found in clusters scattered around the cytoplasm while after 4 h, the proteins were 
found closer to the nucleus, suggesting that BSA-α-Gal is taken up and processed in 
endosomes. 




In conclusion, α-Gal containing proteins are actively and promptly internalized by 
iMDDCs in a time-dependent manner, and the mechanism of internalization seems to be 
α-Gal dependent. Also, the differences in degradation kinetics of proteins carrying α-
Gal and those that do not reflect the delayed onset of symptoms that red meat allergic 
patients experience. Taken together, it is shown that α-Gal is important for antigen 
processing and these results add new knowledge of α-Gal as a clinically relevant food 


























According to the aims set out in section 3, the following conclusions are drawn: 
a) The α-Gal glycosylation hampers the resistance of BSA to pepsinolysis and alters the 
digestion patterns of BSA-α-Gal compared to BSA, whereas large digestion products 
of BSA-α-Gal bearing α-Gal were prolonged time present in the digestion mixture. 
b) The type of glycosylation influence the protein susceptibility to pepsinolysis, α-Gal 
glycosylation hampers the resistance of BSA to pepsinolysis, but NAl glycosylation 
hampers pepsinolysis even more. 
c) The presence of the α-Gal epitope on BSA influences their transport through the 
intestinal Caco-2 monolayer compared to unconjugated BSA and the slower 
transport of BSA-α-Gal is glycosylation specific. 
d) The intact proteins and the α-Gal epitope on the intact protein can be detected in the 
endosomal fraction of Caco-2 cell lysates which implicates the delayed processing of 
α-Gal carrying proteins in the intestinal cells. 
e) The level of pro-inflammatory factors (galectin-3) in the intestinal cells is not 
affected by the presence of BSA-α-Gal in comparison to BSA. 
f) The presence of α-Gal on the protein surface enhances their internalization by 
iMDDCs. 
g) The types of protein glycosylation of antigens influence their uptake by iMDDCs, 
while the size of the protein is not a decisive factor. 
h) The α-Gal glycosylation protects the protein from degradation in the iMDDCs and as 
such may increase their processing time and exposure on the surface of the cell. 
i) The receptor-mediated endocytosis and macropinocytosis are involved in the uptake 
of α-Gal containing proteins by iMDDCs. 








8. Appendix  
Biosafety level risk 
Biological agents of plant, animal, or human origin are classified according to 
biosafety level risk (BSL). This means that work with such agents requires the strict 
following of guidelines for laboratory facilities, safety equipment, and laboratory 
practices and techniques. There are four levels of biological containment (BSL 1 - 4) 
and experiments performed in this doctoral dissertation were performed in laboratories 
that apply BSL-2 containment. This means that agents used in performed experiments 
pose a moderate risk to personnel and the environment (BSL-2 risk) and BSL-2 
containment required lab coats, gloves and face protection, biological safety cabinets 
(Class 2, type A, BSC), decontamination of waste materials, restricted access to 
laboratory and laboratory work supervised by a trained scientist who understands the 
risk associated with used biological agents. 
General cell-culturing protocols  
The work with cell cultures and cell-based models follows some specific assay 
protocols, also some general protocols which are routines in cell-cultures laboratories 
worldwide. 
Thawing cells 
To ensure the maximum survival of cells upon thawing the next general protocol 
should be followed: 
1. The culturing medium should be preheated to 37 °C. 
2. The cryovials containing frozen cells should be inserted into the water bath adjusted 
to 37 °C immediately after removal from liquid nitrogen containers or deep-freezer to 
prevent cell lysis. 
3. Upon defrosting the content, the cryovials should be transferred to the biological 
safety cabinet and the cell suspension should be carefully passed on appropriate volume 
prewarmed culturing, usually 5 mL of culturing medium in a 25 mL flask (T-25). 




4. The cells suspension in the medium should be gently mixed and culturing flask 
should be placed in the incubator for maintaining the optimal conditions for cell culture 
growth.  
5. The following day culturing medium should be changed with a fresh medium to 
increase the survival of still fragile cells and to allow cell adhesion for adherent cell 
cultures also the viability of the cells and eventual presence of contaminants such as 
bacteria should be checked under a microscope. 
Maintaining cell culture 
The cell cultures and cell-based models are usually grown in an air atmosphere 
in incubators which provides them a constant temperature of 37 °C and the optimal 
percentage of CO2. The cell suspension or monolayers are kept in appropriate sterile 
dishes such as flasks, Petri dishes, transwell inserts, etc. in an optimal culturing medium 
usually supplemented with FBS and antibiotics. For optimal cell growth culturing 
medium should be regularly replaced with a fresh one, usually, mediums contain pH 
indicators such as phenol red whose color change signals the level of metabolic activity 
of the cells which results in a change in pH of the culturing medium. The cells grown in 
laboratory conditions follow the cell growth curve (Figure 36) which consist of lag 
phase which reflects the cells recover from sub-cultivation, attach to the surface and 
start to spread, log phase which reflects exponential cells growth and characteristic 
doubling rate of cells which defines the cell line’s doubling time, plateau phase in which 
the culture is confluent and cell growth slows or even stops and eventually death phase 
during which cells start dying and in case of adherent cultures detach from the surface. 
 
Figure 36. Phases of cell cultures growth.
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 Available at https://www.leica-microsystems.com/science-lab/how-to-do-a-proper-cell-culture-quick-
check/ 




It is crucial to ensure viability and stabile proliferation rate, as well as genetic stability 
of the cultured cells for that purpose cells should be kept in their exponential phase of 
growth i.e. log phase. To ensure the mentioned characteristics the cell cultures should be 
sub-cultured before reach the stationary phase of growth. For each cell line, the growth 
curves should be determined since the optimal splitting ratio is evaluated based on it. 
The number of sub-cultures is designated as passage number which must be regularly 
recorded and kept as low as possible. 
Sub-culturing protocol 
For the cell cultures grown in suspension, the sub-culturing protocol is quite 
simple when the growth curve and subsequently splitting ratio was determined. The cell 
suspension should be collected from the culturing vessel, transferred to the appropriate 
tube, and centrifuged to spin down the cells to the bottom of the tube. The residual 
medium should be carefully discarded and optionally the cells can be washed with PBS 
which requires second round centrifugation and the remaining PBS should be discarded. 
The cells should be resuspended in an appropriate volume of fresh medium suitable for 
use in subsequent cell counting and optimal cell splitting.  
For the adherent cells, when cultured cells usually rich 80 – 90% of confluence, 
which can be determined by simple inspection of the cell culture under the microscope, 
sub-culturing is recommended. First cell monolayer should be washed with PBS to 
remove the remaining FBS from the culturing medium, next the cells should be 
detached from the bottom of the vessel by the addition of trypsin or in case of semi-
adherent cells prolonged incubation with PBS and simply tapping the bottom of the 
vessel is enough. The detached cells should be resuspended in a fresh medium 
containing FBS to ensure the inactivation of the trypsin since FBS contains trypsin 
inhibitors. Further, the cell suspension should be centrifuged, a medium should be 
discarded and the cells should be resuspended in an appropriate volume of fresh 
medium suitable for use in subsequent cell counting and optimal cell splitting. 
Cell freezing 
For the long-term storage and preservation of the cell lines, the cells should 
freeze. After passage and cell counting, a definite number of viable cells usually up to 6 
x 10
6 
cells in 1 mL of the freezing solution should be left for storage. The used freezing 




solution must contain a cryoprotective agent such as DMSO or glycerol to reduce the 
detrimental effects which freezing can have on cell viability. The cryoprotective agents 
reduce the freezing point and increase the permeability of the cell membrane to water. 
The cell suspension in freezing solution should be stored at – 80 °C for up to 6 months 
and subsequently transferred in liquid nitrogen for long term storage. 
Cell counting 
Cell counting is performed on regular basis in cell laboratories, for that purpose 
commercial devices so-called cell-counters can be used but cell counting using cell-
counting chambers i.e. hemocytometers is unsurpassed (Figure 37).  
 
Figure 37. Hemocytometer and dimensions of counting grid chambers.
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Before counting to discriminate live and dead cells, cell suspension should be mixed 
with a 0.1 % Trypan blue solution. Trypan blue is an azo dye which penetrates in death 
cell due to impaired membrane permeability while live cells with intact membrane are 
non-colored. The cell suspension mixed with Trypan blue should place on top of 
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 Available at  
https://biocyclopedia.com/index/biotechnology_methods/microbiology/cell_count_by_hemocytometer
_or_measuring_volume.php 




hemocytometer and covered with cover glass. For example if in a square with 
dimensions 1 mm x 1 mm (depth 0.1 mm) the next calculation should be applied: 
                   
                 
                                    ⁄  
Measurement of transepithelial electrical resistance (TEER) 
 The measurement of transepithelial/transendothelial electrical resistance is a 
sensitive and reliable method for confirming the integrity and permeability of the 
monolayer. It is the measurement of electrical resistance across a cellular monolayer. 
For TEER measurement commercial devices are in use (Figure 38).  
 




TEER should be monitored during the differentiation and growth of cells on the 
transwell inserts as well as before and after transport experiments. As blank or control 
empty transwell insert without seeded cells only with medium should be used. Before 
measurement electrodes should be sterilized by dipping the electrodes in 70 % ethanol 
for 15 min, afterward electrodes should be dried on air and dipped in a prewarmed 
culturing medium before measurement. TEER measurement should be performed in a 
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biosafety cabinet to ensure sterile conditions. The average value of three consecutive 
measurements is taken as the TEER value. Usually, TEER is expressed as measured 
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